Gene to GO BP test for over-representation
| GOBPID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031324 | 0.00000 | 2.96915 | 47 | 108 | 2650 | negative regulation of cellular metabolic process |
| GO:0051172 | 0.00000 | 2.93902 | 45 | 102 | 2488 | negative regulation of nitrogen compound metabolic process |
| GO:0051254 | 0.00000 | 3.29241 | 31 | 81 | 1706 | positive regulation of RNA metabolic process |
| GO:0031325 | 0.00000 | 2.71376 | 60 | 122 | 3330 | positive regulation of cellular metabolic process |
| GO:0045935 | 0.00000 | 3.10917 | 34 | 85 | 1899 | positive regulation of nucleobase-containing compound metabolic process |
| GO:0009893 | 0.00000 | 2.62088 | 65 | 128 | 3642 | positive regulation of metabolic process |
| GO:0009891 | 0.00000 | 3.02855 | 36 | 88 | 2025 | positive regulation of biosynthetic process |
| GO:0031328 | 0.00000 | 3.03802 | 36 | 87 | 1992 | positive regulation of cellular biosynthetic process |
| GO:0048523 | 0.00000 | 2.44776 | 88 | 154 | 4903 | negative regulation of cellular process |
| GO:0031327 | 0.00000 | 3.14356 | 29 | 76 | 1647 | negative regulation of cellular biosynthetic process |
| GO:1903508 | 0.00000 | 3.14487 | 29 | 75 | 1621 | positive regulation of nucleic acid-templated transcription |
| GO:0051173 | 0.00000 | 2.59595 | 57 | 115 | 3200 | positive regulation of nitrogen compound metabolic process |
| GO:1902680 | 0.00000 | 3.14265 | 29 | 75 | 1622 | positive regulation of RNA biosynthetic process |
| GO:0000122 | 0.00000 | 4.01315 | 15 | 51 | 839 | negative regulation of transcription by RNA polymerase II |
| GO:2000113 | 0.00000 | 3.21352 | 27 | 71 | 1492 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0009890 | 0.00000 | 3.09182 | 30 | 76 | 1671 | negative regulation of biosynthetic process |
| GO:0045893 | 0.00000 | 3.16942 | 27 | 72 | 1535 | positive regulation of transcription, DNA-templated |
| GO:0010558 | 0.00000 | 3.12340 | 28 | 73 | 1580 | negative regulation of macromolecule biosynthetic process |
| GO:1903507 | 0.00000 | 3.36687 | 23 | 64 | 1270 | negative regulation of nucleic acid-templated transcription |
| GO:1902679 | 0.00000 | 3.36090 | 23 | 64 | 1272 | negative regulation of RNA biosynthetic process |
| GO:0045892 | 0.00000 | 3.39070 | 22 | 62 | 1217 | negative regulation of transcription, DNA-templated |
| GO:0051253 | 0.00000 | 3.24606 | 24 | 66 | 1359 | negative regulation of RNA metabolic process |
| GO:0045944 | 0.00000 | 3.36103 | 22 | 61 | 1204 | positive regulation of transcription by RNA polymerase II |
| GO:0045934 | 0.00000 | 3.09943 | 27 | 69 | 1490 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0010604 | 0.00000 | 2.46997 | 60 | 116 | 3366 | positive regulation of macromolecule metabolic process |
| GO:0010557 | 0.00000 | 2.84431 | 34 | 79 | 1880 | positive regulation of macromolecule biosynthetic process |
| GO:0072359 | 0.00000 | 3.32951 | 21 | 59 | 1169 | circulatory system development |
| GO:0009889 | 0.00000 | 2.32218 | 79 | 138 | 4404 | regulation of biosynthetic process |
| GO:0031326 | 0.00000 | 2.31968 | 77 | 136 | 4325 | regulation of cellular biosynthetic process |
| GO:0010628 | 0.00000 | 2.76604 | 36 | 82 | 2012 | positive regulation of gene expression |
| GO:0006357 | 0.00000 | 2.49273 | 48 | 97 | 2683 | regulation of transcription by RNA polymerase II |
| GO:0009719 | 0.00000 | 2.84915 | 30 | 71 | 1658 | response to endogenous stimulus |
| GO:0031323 | 0.00000 | 2.11255 | 113 | 172 | 6305 | regulation of cellular metabolic process |
| GO:0080090 | 0.00000 | 2.09830 | 112 | 170 | 6233 | regulation of primary metabolic process |
| GO:0048519 | 0.00000 | 2.08424 | 105 | 162 | 5869 | negative regulation of biological process |
| GO:0006366 | 0.00000 | 2.34875 | 50 | 97 | 2818 | transcription by RNA polymerase II |
| GO:0010033 | 0.00000 | 2.26550 | 59 | 108 | 3302 | response to organic substance |
| GO:0009892 | 0.00000 | 2.21727 | 63 | 113 | 3549 | negative regulation of metabolic process |
| GO:0009725 | 0.00000 | 3.18895 | 18 | 49 | 987 | response to hormone |
| GO:0001944 | 0.00000 | 3.46965 | 14 | 43 | 792 | vasculature development |
| GO:0010648 | 0.00000 | 2.79353 | 25 | 61 | 1419 | negative regulation of cell communication |
| GO:0072358 | 0.00000 | 3.42670 | 14 | 43 | 801 | cardiovascular system development |
| GO:0023057 | 0.00000 | 2.78467 | 25 | 61 | 1423 | negative regulation of signaling |
| GO:0010605 | 0.00000 | 2.22366 | 59 | 107 | 3314 | negative regulation of macromolecule metabolic process |
| GO:0070887 | 0.00000 | 2.22001 | 59 | 106 | 3281 | cellular response to chemical stimulus |
| GO:2001141 | 0.00000 | 2.16599 | 64 | 112 | 3576 | regulation of RNA biosynthetic process |
| GO:0010556 | 0.00000 | 2.10683 | 74 | 124 | 4138 | regulation of macromolecule biosynthetic process |
| GO:0009628 | 0.00000 | 2.86092 | 22 | 55 | 1237 | response to abiotic stimulus |
| GO:0071310 | 0.00000 | 2.28550 | 48 | 92 | 2707 | cellular response to organic substance |
| GO:0006915 | 0.00000 | 2.44198 | 36 | 74 | 1988 | apoptotic process |
| GO:0006355 | 0.00000 | 2.13044 | 63 | 109 | 3506 | regulation of transcription, DNA-templated |
| GO:0009968 | 0.00000 | 2.73697 | 23 | 56 | 1313 | negative regulation of signal transduction |
| GO:1903506 | 0.00000 | 2.11358 | 64 | 110 | 3567 | regulation of nucleic acid-templated transcription |
| GO:2000112 | 0.00000 | 2.06285 | 72 | 119 | 3998 | regulation of cellular macromolecule biosynthetic process |
| GO:0019219 | 0.00000 | 2.05067 | 74 | 122 | 4140 | regulation of nucleobase-containing compound metabolic process |
| GO:0042326 | 0.00000 | 4.03253 | 8 | 30 | 468 | negative regulation of phosphorylation |
| GO:1901362 | 0.00000 | 2.01046 | 81 | 129 | 4500 | organic cyclic compound biosynthetic process |
| GO:0034654 | 0.00000 | 2.01592 | 77 | 124 | 4278 | nucleobase-containing compound biosynthetic process |
| GO:0051171 | 0.00000 | 1.93675 | 108 | 160 | 6063 | regulation of nitrogen compound metabolic process |
| GO:0008219 | 0.00000 | 2.29000 | 41 | 79 | 2264 | cell death |
| GO:0042127 | 0.00000 | 2.46823 | 30 | 65 | 1700 | regulation of cell proliferation |
| GO:0051252 | 0.00000 | 2.04422 | 68 | 114 | 3822 | regulation of RNA metabolic process |
| GO:0008283 | 0.00000 | 2.34894 | 36 | 73 | 2024 | cell proliferation |
| GO:0032774 | 0.00000 | 2.05020 | 67 | 112 | 3733 | RNA biosynthetic process |
| GO:0044706 | 0.00000 | 5.71798 | 4 | 20 | 222 | multi-multicellular organism process |
| GO:0001568 | 0.00000 | 3.22525 | 14 | 39 | 761 | blood vessel development |
| GO:0001933 | 0.00000 | 4.09255 | 8 | 28 | 429 | negative regulation of protein phosphorylation |
| GO:1901700 | 0.00000 | 2.47567 | 29 | 63 | 1637 | response to oxygen-containing compound |
| GO:0051248 | 0.00000 | 2.72600 | 21 | 51 | 1188 | negative regulation of protein metabolic process |
| GO:0032269 | 0.00000 | 2.77434 | 20 | 49 | 1119 | negative regulation of cellular protein metabolic process |
| GO:0012501 | 0.00000 | 2.29169 | 38 | 75 | 2132 | programmed cell death |
| GO:0018130 | 0.00000 | 1.97698 | 78 | 124 | 4341 | heterocycle biosynthetic process |
| GO:0031400 | 0.00000 | 3.44502 | 11 | 34 | 618 | negative regulation of protein modification process |
| GO:0010941 | 0.00000 | 2.40985 | 31 | 65 | 1736 | regulation of cell death |
| GO:0019438 | 0.00000 | 1.97091 | 78 | 124 | 4351 | aromatic compound biosynthetic process |
| GO:0071495 | 0.00000 | 2.56115 | 25 | 56 | 1393 | cellular response to endogenous stimulus |
| GO:0042221 | 0.00000 | 1.93968 | 86 | 133 | 4797 | response to chemical |
| GO:0016070 | 0.00000 | 1.91419 | 93 | 141 | 5206 | RNA metabolic process |
| GO:0006351 | 0.00000 | 2.01142 | 66 | 109 | 3668 | transcription, DNA-templated |
| GO:0097659 | 0.00000 | 2.00596 | 66 | 110 | 3716 | nucleic acid-templated transcription |
| GO:0043067 | 0.00000 | 2.41641 | 29 | 61 | 1613 | regulation of programmed cell death |
| GO:0009888 | 0.00000 | 2.25349 | 37 | 72 | 2065 | tissue development |
| GO:0006468 | 0.00000 | 2.27631 | 35 | 70 | 1983 | protein phosphorylation |
| GO:0014070 | 0.00000 | 2.87721 | 16 | 42 | 915 | response to organic cyclic compound |
| GO:0042981 | 0.00000 | 2.41048 | 28 | 60 | 1587 | regulation of apoptotic process |
| GO:0045936 | 0.00000 | 3.40106 | 10 | 32 | 586 | negative regulation of phosphate metabolic process |
| GO:0010563 | 0.00000 | 3.39474 | 11 | 32 | 587 | negative regulation of phosphorus metabolic process |
| GO:0048513 | 0.00000 | 1.98681 | 64 | 106 | 3583 | animal organ development |
| GO:0019222 | 0.00000 | 1.83997 | 131 | 180 | 7303 | regulation of metabolic process |
| GO:1901360 | 0.00000 | 1.83573 | 122 | 171 | 6839 | organic cyclic compound metabolic process |
| GO:0048545 | 0.00000 | 4.03991 | 7 | 25 | 385 | response to steroid hormone |
| GO:0035295 | 0.00000 | 2.66103 | 20 | 47 | 1110 | tube development |
| GO:0001666 | 0.00000 | 4.16008 | 6 | 24 | 359 | response to hypoxia |
| GO:1904018 | 0.00000 | 5.18130 | 4 | 19 | 230 | positive regulation of vasculature development |
| GO:0048585 | 0.00000 | 2.33462 | 30 | 62 | 1693 | negative regulation of response to stimulus |
| GO:0009612 | 0.00000 | 5.38291 | 4 | 18 | 210 | response to mechanical stimulus |
| GO:0070482 | 0.00000 | 3.93941 | 7 | 25 | 394 | response to oxygen levels |
| GO:0036293 | 0.00000 | 4.02536 | 7 | 24 | 370 | response to decreased oxygen levels |
| GO:0034097 | 0.00000 | 2.54107 | 22 | 49 | 1211 | response to cytokine |
| GO:0007565 | 0.00000 | 5.56534 | 3 | 17 | 192 | female pregnancy |
| GO:1901652 | 0.00000 | 3.45568 | 9 | 29 | 520 | response to peptide |
| GO:0009058 | 0.00000 | 1.80917 | 113 | 160 | 6339 | biosynthetic process |
| GO:0048731 | 0.00000 | 1.85007 | 88 | 132 | 4918 | system development |
| GO:0030154 | 0.00000 | 1.88440 | 76 | 118 | 4239 | cell differentiation |
| GO:0051094 | 0.00000 | 2.39969 | 25 | 54 | 1418 | positive regulation of developmental process |
| GO:0048522 | 0.00000 | 1.81873 | 98 | 143 | 5490 | positive regulation of cellular process |
| GO:0042493 | 0.00000 | 2.62263 | 18 | 43 | 1021 | response to drug |
| GO:0061061 | 0.00000 | 3.03631 | 12 | 33 | 672 | muscle structure development |
| GO:0090304 | 0.00000 | 1.79333 | 103 | 147 | 5735 | nucleic acid metabolic process |
| GO:0044271 | 0.00000 | 1.81641 | 90 | 133 | 5029 | cellular nitrogen compound biosynthetic process |
| GO:0048518 | 0.00000 | 1.78056 | 112 | 157 | 6254 | positive regulation of biological process |
| GO:0006139 | 0.00000 | 1.77774 | 115 | 160 | 6411 | nucleobase-containing compound metabolic process |
| GO:1901576 | 0.00000 | 1.77837 | 112 | 157 | 6259 | organic substance biosynthetic process |
| GO:0010629 | 0.00000 | 2.05259 | 44 | 78 | 2448 | negative regulation of gene expression |
| GO:0033554 | 0.00000 | 2.12676 | 37 | 69 | 2069 | cellular response to stress |
| GO:0033993 | 0.00000 | 2.68919 | 17 | 40 | 923 | response to lipid |
| GO:0042325 | 0.00000 | 2.26622 | 29 | 58 | 1614 | regulation of phosphorylation |
| GO:0071496 | 0.00000 | 4.00811 | 6 | 22 | 339 | cellular response to external stimulus |
| GO:0048514 | 0.00000 | 2.99262 | 12 | 33 | 681 | blood vessel morphogenesis |
| GO:0016310 | 0.00000 | 2.04811 | 43 | 77 | 2417 | phosphorylation |
| GO:0009059 | 0.00000 | 1.79689 | 91 | 134 | 5114 | macromolecule biosynthetic process |
| GO:0071345 | 0.00000 | 2.50514 | 20 | 45 | 1118 | cellular response to cytokine stimulus |
| GO:0050793 | 0.00000 | 1.98976 | 48 | 83 | 2696 | regulation of developmental process |
| GO:0006725 | 0.00000 | 1.75574 | 118 | 163 | 6615 | cellular aromatic compound metabolic process |
| GO:0046483 | 0.00000 | 1.75320 | 118 | 162 | 6570 | heterocycle metabolic process |
| GO:0044092 | 0.00000 | 2.46453 | 21 | 46 | 1162 | negative regulation of molecular function |
| GO:0050678 | 0.00000 | 3.74587 | 7 | 23 | 378 | regulation of epithelial cell proliferation |
| GO:0060537 | 0.00000 | 3.61935 | 7 | 24 | 408 | muscle tissue development |
| GO:0051384 | 0.00000 | 6.03352 | 3 | 14 | 146 | response to glucocorticoid |
| GO:0010646 | 0.00000 | 1.87638 | 63 | 101 | 3542 | regulation of cell communication |
| GO:0009966 | 0.00000 | 1.91366 | 57 | 93 | 3170 | regulation of signal transduction |
| GO:0019216 | 0.00000 | 3.60020 | 7 | 24 | 410 | regulation of lipid metabolic process |
| GO:0044238 | 0.00000 | 1.81842 | 202 | 245 | 11287 | primary metabolic process |
| GO:0035556 | 0.00000 | 1.93251 | 53 | 88 | 2952 | intracellular signal transduction |
| GO:0019220 | 0.00000 | 2.15491 | 32 | 62 | 1816 | regulation of phosphate metabolic process |
| GO:0051174 | 0.00000 | 2.15220 | 33 | 62 | 1818 | regulation of phosphorus metabolic process |
| GO:0048869 | 0.00000 | 1.80012 | 79 | 119 | 4431 | cellular developmental process |
| GO:0045444 | 0.00000 | 4.71976 | 4 | 17 | 223 | fat cell differentiation |
| GO:0034641 | 0.00000 | 1.72377 | 128 | 172 | 7161 | cellular nitrogen compound metabolic process |
| GO:0001932 | 0.00000 | 2.26067 | 26 | 53 | 1465 | regulation of protein phosphorylation |
| GO:0044249 | 0.00000 | 1.73150 | 110 | 153 | 6168 | cellular biosynthetic process |
| GO:0023051 | 0.00000 | 1.84395 | 64 | 101 | 3591 | regulation of signaling |
| GO:0034645 | 0.00000 | 1.75862 | 89 | 129 | 4961 | cellular macromolecule biosynthetic process |
| GO:0007507 | 0.00000 | 3.02933 | 11 | 29 | 587 | heart development |
| GO:0033673 | 0.00000 | 4.31315 | 5 | 18 | 257 | negative regulation of kinase activity |
| GO:0051348 | 0.00000 | 4.09751 | 5 | 19 | 285 | negative regulation of transferase activity |
| GO:0043549 | 0.00000 | 2.61766 | 16 | 37 | 870 | regulation of kinase activity |
| GO:0060255 | 0.00000 | 1.70692 | 121 | 164 | 6785 | regulation of macromolecule metabolic process |
| GO:0002040 | 0.00000 | 5.08509 | 3 | 15 | 183 | sprouting angiogenesis |
| GO:1901701 | 0.00000 | 2.39591 | 20 | 44 | 1136 | cellular response to oxygen-containing compound |
| GO:0050673 | 0.00000 | 3.38493 | 8 | 24 | 434 | epithelial cell proliferation |
| GO:0009991 | 0.00000 | 3.11168 | 9 | 27 | 531 | response to extracellular stimulus |
| GO:0043434 | 0.00000 | 3.36812 | 8 | 24 | 436 | response to peptide hormone |
| GO:0006469 | 0.00000 | 4.45701 | 4 | 17 | 235 | negative regulation of protein kinase activity |
| GO:0008284 | 0.00000 | 2.52578 | 17 | 39 | 951 | positive regulation of cell proliferation |
| GO:0031960 | 0.00000 | 5.37652 | 3 | 14 | 162 | response to corticosteroid |
| GO:0035239 | 0.00000 | 2.54049 | 16 | 38 | 920 | tube morphogenesis |
| GO:0005996 | 0.00000 | 3.99089 | 5 | 19 | 292 | monosaccharide metabolic process |
| GO:0065009 | 0.00000 | 1.87328 | 53 | 87 | 2989 | regulation of molecular function |
| GO:0010631 | 0.00000 | 3.66082 | 6 | 21 | 351 | epithelial cell migration |
| GO:0010243 | 0.00000 | 2.46801 | 18 | 40 | 998 | response to organonitrogen compound |
| GO:0044237 | 0.00000 | 1.75752 | 202 | 243 | 11301 | cellular metabolic process |
| GO:0090132 | 0.00000 | 3.62723 | 6 | 21 | 354 | epithelium migration |
| GO:0043618 | 0.00000 | 6.23181 | 2 | 12 | 121 | regulation of transcription from RNA polymerase II promoter in response to stress |
| GO:0042594 | 0.00000 | 4.85181 | 3 | 15 | 191 | response to starvation |
| GO:0043069 | 0.00000 | 2.50467 | 17 | 38 | 932 | negative regulation of programmed cell death |
| GO:0007167 | 0.00000 | 2.41563 | 19 | 41 | 1045 | enzyme linked receptor protein signaling pathway |
| GO:0043542 | 0.00000 | 4.03894 | 5 | 18 | 273 | endothelial cell migration |
| GO:0045859 | 0.00000 | 2.62820 | 14 | 34 | 792 | regulation of protein kinase activity |
| GO:0090130 | 0.00000 | 3.56185 | 6 | 21 | 360 | tissue migration |
| GO:1901342 | 0.00000 | 3.32464 | 8 | 23 | 422 | regulation of vasculature development |
| GO:0031399 | 0.00000 | 2.04514 | 33 | 61 | 1867 | regulation of protein modification process |
| GO:0001525 | 0.00000 | 2.90993 | 11 | 28 | 587 | angiogenesis |
| GO:0044260 | 0.00000 | 1.66528 | 149 | 191 | 8352 | cellular macromolecule metabolic process |
| GO:0030324 | 0.00000 | 5.03347 | 3 | 14 | 172 | lung development |
| GO:0060548 | 0.00000 | 2.40178 | 18 | 40 | 1023 | negative regulation of cell death |
| GO:1902531 | 0.00000 | 2.01337 | 35 | 63 | 1961 | regulation of intracellular signal transduction |
| GO:0001659 | 0.00000 | 5.00153 | 3 | 14 | 173 | temperature homeostasis |
| GO:0043066 | 0.00000 | 2.48902 | 16 | 37 | 911 | negative regulation of apoptotic process |
| GO:0060541 | 0.00000 | 4.66442 | 4 | 15 | 198 | respiratory system development |
| GO:0043620 | 0.00000 | 5.90473 | 2 | 12 | 127 | regulation of DNA-templated transcription in response to stress |
| GO:0001667 | 0.00000 | 3.17100 | 8 | 24 | 461 | ameboidal-type cell migration |
| GO:0035914 | 0.00000 | 8.57851 | 1 | 9 | 68 | skeletal muscle cell differentiation |
| GO:0007275 | 0.00000 | 1.68623 | 98 | 137 | 5491 | multicellular organism development |
| GO:0030323 | 0.00000 | 4.90810 | 3 | 14 | 176 | respiratory tube development |
| GO:0032870 | 0.00000 | 2.69763 | 13 | 31 | 701 | cellular response to hormone stimulus |
| GO:0007154 | 0.00000 | 1.65918 | 119 | 159 | 6647 | cell communication |
| GO:0051716 | 0.00000 | 1.65108 | 136 | 177 | 7617 | cellular response to stimulus |
| GO:0010594 | 0.00000 | 4.28098 | 4 | 16 | 229 | regulation of endothelial cell migration |
| GO:0006950 | 0.00000 | 1.73569 | 74 | 109 | 4110 | response to stress |
| GO:0051240 | 0.00000 | 2.03083 | 32 | 59 | 1811 | positive regulation of multicellular organismal process |
| GO:0045766 | 0.00000 | 4.51485 | 4 | 15 | 204 | positive regulation of angiogenesis |
| GO:0044262 | 0.00000 | 3.84026 | 5 | 18 | 286 | cellular carbohydrate metabolic process |
| GO:0043534 | 0.00000 | 4.78878 | 3 | 14 | 180 | blood vessel endothelial cell migration |
| GO:0050679 | 0.00000 | 4.46708 | 4 | 15 | 206 | positive regulation of epithelial cell proliferation |
| GO:0051246 | 0.00000 | 1.82420 | 53 | 84 | 2936 | regulation of protein metabolic process |
| GO:0002064 | 0.00001 | 4.44357 | 4 | 15 | 207 | epithelial cell development |
| GO:0051338 | 0.00001 | 2.39191 | 17 | 38 | 972 | regulation of transferase activity |
| GO:0010468 | 0.00001 | 1.67931 | 92 | 129 | 5127 | regulation of gene expression |
| GO:0071407 | 0.00001 | 2.91528 | 10 | 26 | 542 | cellular response to organic cyclic compound |
| GO:0010632 | 0.00001 | 3.76888 | 5 | 18 | 291 | regulation of epithelial cell migration |
| GO:0051365 | 0.00001 | Inf | 0 | 3 | 3 | cellular response to potassium ion starvation |
| GO:0048646 | 0.00001 | 2.24997 | 21 | 43 | 1173 | anatomical structure formation involved in morphogenesis |
| GO:0045595 | 0.00001 | 1.98959 | 34 | 60 | 1878 | regulation of cell differentiation |
| GO:0031668 | 0.00001 | 3.86398 | 5 | 17 | 268 | cellular response to extracellular stimulus |
| GO:0006464 | 0.00001 | 1.70829 | 74 | 109 | 4160 | cellular protein modification process |
| GO:0036211 | 0.00001 | 1.70829 | 74 | 109 | 4160 | protein modification process |
| GO:0023052 | 0.00001 | 1.62949 | 118 | 157 | 6620 | signaling |
| GO:0014706 | 0.00001 | 3.26681 | 7 | 21 | 390 | striated muscle tissue development |
| GO:0043408 | 0.00001 | 2.53383 | 14 | 32 | 768 | regulation of MAPK cascade |
| GO:0005975 | 0.00001 | 2.71889 | 11 | 28 | 625 | carbohydrate metabolic process |
| GO:0009605 | 0.00001 | 1.84895 | 45 | 74 | 2520 | response to external stimulus |
| GO:0070848 | 0.00001 | 2.55863 | 13 | 31 | 736 | response to growth factor |
| GO:0002042 | 0.00001 | 6.40011 | 2 | 10 | 98 | cell migration involved in sprouting angiogenesis |
| GO:0106106 | 0.00001 | 5.17899 | 3 | 12 | 143 | cold-induced thermogenesis |
| GO:0120161 | 0.00001 | 5.17899 | 3 | 12 | 143 | regulation of cold-induced thermogenesis |
| GO:0040017 | 0.00001 | 2.73624 | 11 | 27 | 598 | positive regulation of locomotion |
| GO:0043086 | 0.00001 | 2.46103 | 15 | 33 | 815 | negative regulation of catalytic activity |
| GO:0071363 | 0.00001 | 2.57805 | 13 | 30 | 706 | cellular response to growth factor stimulus |
| GO:0019318 | 0.00001 | 3.90920 | 4 | 16 | 249 | hexose metabolic process |
| GO:0042110 | 0.00001 | 3.00096 | 8 | 23 | 464 | T cell activation |
| GO:0051090 | 0.00001 | 3.08296 | 8 | 22 | 432 | regulation of DNA-binding transcription factor activity |
| GO:1902532 | 0.00001 | 2.78196 | 10 | 26 | 566 | negative regulation of intracellular signal transduction |
| GO:0032268 | 0.00001 | 1.81171 | 48 | 77 | 2679 | regulation of cellular protein metabolic process |
| GO:1901698 | 0.00001 | 2.24211 | 19 | 40 | 1089 | response to nitrogen compound |
| GO:0010634 | 0.00001 | 4.65937 | 3 | 13 | 171 | positive regulation of epithelial cell migration |
| GO:0032922 | 0.00001 | 8.30811 | 1 | 8 | 62 | circadian regulation of gene expression |
| GO:0071704 | 0.00002 | 1.68569 | 216 | 252 | 12093 | organic substance metabolic process |
| GO:0051239 | 0.00002 | 1.73728 | 58 | 89 | 3260 | regulation of multicellular organismal process |
| GO:2000026 | 0.00002 | 1.87626 | 39 | 65 | 2157 | regulation of multicellular organismal development |
| GO:0030335 | 0.00002 | 2.77747 | 10 | 25 | 544 | positive regulation of cell migration |
| GO:0001936 | 0.00002 | 4.51520 | 3 | 13 | 176 | regulation of endothelial cell proliferation |
| GO:1903672 | 0.00002 | 8.01052 | 1 | 8 | 64 | positive regulation of sprouting angiogenesis |
| GO:0008285 | 0.00002 | 2.47102 | 14 | 31 | 760 | negative regulation of cell proliferation |
| GO:0030334 | 0.00002 | 2.30270 | 17 | 36 | 950 | regulation of cell migration |
| GO:0061614 | 0.00002 | 9.79144 | 1 | 7 | 47 | pri-miRNA transcription by RNA polymerase II |
| GO:0010595 | 0.00002 | 5.30309 | 2 | 11 | 128 | positive regulation of endothelial cell migration |
| GO:0045597 | 0.00002 | 2.26985 | 18 | 37 | 991 | positive regulation of cell differentiation |
| GO:0071417 | 0.00002 | 2.68454 | 10 | 26 | 585 | cellular response to organonitrogen compound |
| GO:0006807 | 0.00002 | 1.62051 | 193 | 230 | 10812 | nitrogen compound metabolic process |
| GO:0010942 | 0.00002 | 2.48628 | 13 | 30 | 730 | positive regulation of cell death |
| GO:1990845 | 0.00002 | 4.77491 | 3 | 12 | 154 | adaptive thermogenesis |
| GO:0000165 | 0.00002 | 2.28168 | 17 | 36 | 958 | MAPK cascade |
| GO:1901653 | 0.00002 | 3.13603 | 7 | 20 | 385 | cellular response to peptide |
| GO:0006979 | 0.00002 | 2.94329 | 8 | 22 | 451 | response to oxidative stress |
| GO:0071456 | 0.00002 | 4.11273 | 4 | 14 | 207 | cellular response to hypoxia |
| GO:0036003 | 0.00002 | 12.40447 | 1 | 6 | 33 | positive regulation of transcription from RNA polymerase II promoter in response to stress |
| GO:0007165 | 0.00002 | 1.59313 | 110 | 146 | 6155 | signal transduction |
| GO:0050896 | 0.00002 | 1.58575 | 167 | 204 | 9324 | response to stimulus |
| GO:0007623 | 0.00002 | 4.09130 | 4 | 14 | 208 | circadian rhythm |
| GO:0043535 | 0.00002 | 4.70807 | 3 | 12 | 156 | regulation of blood vessel endothelial cell migration |
| GO:0010467 | 0.00002 | 1.58380 | 118 | 154 | 6585 | gene expression |
| GO:0043412 | 0.00003 | 1.64370 | 78 | 111 | 4373 | macromolecule modification |
| GO:0040012 | 0.00003 | 2.18749 | 19 | 39 | 1084 | regulation of locomotion |
| GO:0009636 | 0.00003 | 2.75604 | 9 | 24 | 525 | response to toxic substance |
| GO:0023014 | 0.00003 | 2.25335 | 17 | 36 | 969 | signal transduction by protein phosphorylation |
| GO:0036499 | 0.00003 | 17.40122 | 0 | 5 | 21 | PERK-mediated unfolded protein response |
| GO:0051412 | 0.00003 | 17.40122 | 0 | 5 | 21 | response to corticosterone |
| GO:0030217 | 0.00003 | 3.78495 | 4 | 15 | 240 | T cell differentiation |
| GO:2000145 | 0.00003 | 2.21828 | 18 | 37 | 1012 | regulation of cell motility |
| GO:0048583 | 0.00003 | 1.63660 | 78 | 110 | 4342 | regulation of response to stimulus |
| GO:0006796 | 0.00003 | 1.69827 | 59 | 89 | 3320 | phosphate-containing compound metabolic process |
| GO:0001938 | 0.00003 | 5.51743 | 2 | 10 | 112 | positive regulation of endothelial cell proliferation |
| GO:2000147 | 0.00004 | 2.65113 | 10 | 25 | 568 | positive regulation of cell motility |
| GO:0031667 | 0.00004 | 2.77487 | 9 | 23 | 499 | response to nutrient levels |
| GO:1903670 | 0.00004 | 4.92186 | 2 | 11 | 137 | regulation of sprouting angiogenesis |
| GO:0036294 | 0.00004 | 3.90797 | 4 | 14 | 217 | cellular response to decreased oxygen levels |
| GO:0060428 | 0.00004 | 11.16220 | 1 | 6 | 36 | lung epithelium development |
| GO:0001935 | 0.00004 | 4.13130 | 3 | 13 | 191 | endothelial cell proliferation |
| GO:0038066 | 0.00004 | 8.51150 | 1 | 7 | 53 | p38MAPK cascade |
| GO:0006793 | 0.00004 | 1.68119 | 60 | 89 | 3347 | phosphorus metabolic process |
| GO:0001822 | 0.00004 | 3.47093 | 5 | 16 | 278 | kidney development |
| GO:0009653 | 0.00004 | 1.73675 | 49 | 76 | 2735 | anatomical structure morphogenesis |
| GO:0043114 | 0.00005 | 10.80153 | 1 | 6 | 37 | regulation of vascular permeability |
| GO:0090050 | 0.00005 | 10.80153 | 1 | 6 | 37 | positive regulation of cell migration involved in sprouting angiogenesis |
| GO:0071383 | 0.00005 | 3.62189 | 4 | 15 | 250 | cellular response to steroid hormone stimulus |
| GO:0022603 | 0.00005 | 2.10134 | 21 | 40 | 1155 | regulation of anatomical structure morphogenesis |
| GO:0030522 | 0.00005 | 3.44425 | 5 | 16 | 280 | intracellular receptor signaling pathway |
| GO:0002237 | 0.00005 | 3.15675 | 6 | 18 | 343 | response to molecule of bacterial origin |
| GO:0043170 | 0.00005 | 1.57298 | 188 | 223 | 10507 | macromolecule metabolic process |
| GO:0048870 | 0.00005 | 1.89095 | 31 | 54 | 1751 | cell motility |
| GO:0051674 | 0.00005 | 1.89095 | 31 | 54 | 1751 | localization of cell |
| GO:0030155 | 0.00005 | 2.43912 | 12 | 28 | 691 | regulation of cell adhesion |
| GO:0048856 | 0.00006 | 1.56047 | 107 | 141 | 5988 | anatomical structure development |
| GO:0043435 | 0.00006 | 83.08459 | 0 | 3 | 5 | response to corticotropin-releasing hormone |
| GO:0071376 | 0.00006 | 83.08459 | 0 | 3 | 5 | cellular response to corticotropin-releasing hormone stimulus |
| GO:0051272 | 0.00006 | 2.56819 | 10 | 25 | 585 | positive regulation of cellular component movement |
| GO:0046697 | 0.00006 | 14.65126 | 0 | 5 | 24 | decidualization |
| GO:0002521 | 0.00006 | 2.68222 | 9 | 23 | 515 | leukocyte differentiation |
| GO:0030097 | 0.00006 | 2.24430 | 16 | 33 | 887 | hemopoiesis |
| GO:0060429 | 0.00006 | 2.02326 | 23 | 43 | 1291 | epithelium development |
| GO:0051591 | 0.00006 | 5.74238 | 2 | 9 | 97 | response to cAMP |
| GO:0043116 | 0.00006 | 24.68283 | 0 | 4 | 13 | negative regulation of vascular permeability |
| GO:0061469 | 0.00006 | 24.68283 | 0 | 4 | 13 | regulation of type B pancreatic cell proliferation |
| GO:0048534 | 0.00006 | 2.20854 | 17 | 34 | 929 | hematopoietic or lymphoid organ development |
| GO:0030855 | 0.00006 | 2.33014 | 14 | 30 | 775 | epithelial cell differentiation |
| GO:0045765 | 0.00007 | 2.97809 | 7 | 19 | 383 | regulation of angiogenesis |
| GO:0007166 | 0.00007 | 1.68352 | 55 | 82 | 3052 | cell surface receptor signaling pathway |
| GO:0003007 | 0.00007 | 3.48656 | 5 | 15 | 259 | heart morphogenesis |
| GO:0008643 | 0.00007 | 4.52394 | 3 | 11 | 148 | carbohydrate transport |
| GO:0009267 | 0.00008 | 4.49091 | 3 | 11 | 149 | cellular response to starvation |
| GO:0010562 | 0.00008 | 2.06751 | 20 | 39 | 1141 | positive regulation of phosphorus metabolic process |
| GO:0045937 | 0.00008 | 2.06751 | 20 | 39 | 1141 | positive regulation of phosphate metabolic process |
| GO:0072001 | 0.00008 | 3.28025 | 5 | 16 | 293 | renal system development |
| GO:0009896 | 0.00008 | 2.83432 | 8 | 20 | 423 | positive regulation of catabolic process |
| GO:0003151 | 0.00008 | 6.31297 | 1 | 8 | 79 | outflow tract morphogenesis |
| GO:0043536 | 0.00008 | 6.31297 | 1 | 8 | 79 | positive regulation of blood vessel endothelial cell migration |
| GO:0071453 | 0.00009 | 3.60261 | 4 | 14 | 234 | cellular response to oxygen levels |
| GO:0046629 | 0.00009 | 22.21333 | 0 | 4 | 14 | gamma-delta T cell activation |
| GO:0001823 | 0.00009 | 5.43216 | 2 | 9 | 102 | mesonephros development |
| GO:0008152 | 0.00009 | 1.61220 | 225 | 256 | 12552 | metabolic process |
| GO:0031331 | 0.00010 | 2.98810 | 6 | 18 | 361 | positive regulation of cellular catabolic process |
| GO:0062013 | 0.00010 | 4.36345 | 3 | 11 | 153 | positive regulation of small molecule metabolic process |
| GO:0043068 | 0.00010 | 2.38160 | 12 | 27 | 680 | positive regulation of programmed cell death |
| GO:0032496 | 0.00010 | 3.08797 | 6 | 17 | 330 | response to lipopolysaccharide |
| GO:0071214 | 0.00010 | 3.07796 | 6 | 17 | 331 | cellular response to abiotic stimulus |
| GO:0104004 | 0.00010 | 3.07796 | 6 | 17 | 331 | cellular response to environmental stimulus |
| GO:0006006 | 0.00010 | 3.74817 | 4 | 13 | 209 | glucose metabolic process |
| GO:0003170 | 0.00010 | 7.24737 | 1 | 7 | 61 | heart valve development |
| GO:0006090 | 0.00011 | 4.33270 | 3 | 11 | 154 | pyruvate metabolic process |
| GO:0090049 | 0.00011 | 6.05604 | 1 | 8 | 82 | regulation of cell migration involved in sprouting angiogenesis |
| GO:0060426 | 0.00011 | 55.38671 | 0 | 3 | 6 | lung vasculature development |
| GO:1901699 | 0.00011 | 2.40408 | 12 | 26 | 648 | cellular response to nitrogen compound |
| GO:0048569 | 0.00012 | 20.19284 | 0 | 4 | 15 | post-embryonic animal organ development |
| GO:0030856 | 0.00012 | 4.27247 | 3 | 11 | 156 | regulation of epithelial cell differentiation |
| GO:0032868 | 0.00012 | 3.30782 | 5 | 15 | 272 | response to insulin |
| GO:0043409 | 0.00012 | 3.93558 | 3 | 12 | 184 | negative regulation of MAPK cascade |
| GO:0016477 | 0.00013 | 1.87117 | 28 | 49 | 1592 | cell migration |
| GO:0016051 | 0.00013 | 3.65393 | 4 | 13 | 214 | carbohydrate biosynthetic process |
| GO:0045598 | 0.00013 | 4.60787 | 2 | 10 | 132 | regulation of fat cell differentiation |
| GO:1904659 | 0.00014 | 5.10126 | 2 | 9 | 108 | glucose transmembrane transport |
| GO:0046683 | 0.00015 | 4.53305 | 2 | 10 | 134 | response to organophosphorus |
| GO:0051270 | 0.00016 | 2.03040 | 20 | 37 | 1097 | regulation of cellular component movement |
| GO:0071900 | 0.00016 | 2.55205 | 9 | 22 | 515 | regulation of protein serine/threonine kinase activity |
| GO:1903825 | 0.00016 | 4.49654 | 2 | 10 | 135 | organic acid transmembrane transport |
| GO:1905039 | 0.00016 | 4.49654 | 2 | 10 | 135 | carboxylic acid transmembrane transport |
| GO:0046320 | 0.00018 | 11.13131 | 1 | 5 | 30 | regulation of fatty acid oxidation |
| GO:1900744 | 0.00018 | 8.16255 | 1 | 6 | 47 | regulation of p38MAPK cascade |
| GO:0050863 | 0.00018 | 3.04554 | 6 | 16 | 314 | regulation of T cell activation |
| GO:0008645 | 0.00018 | 4.90208 | 2 | 9 | 112 | hexose transmembrane transport |
| GO:0031077 | 0.00019 | 41.53776 | 0 | 3 | 7 | post-embryonic camera-type eye development |
| GO:0046643 | 0.00019 | 41.53776 | 0 | 3 | 7 | regulation of gamma-delta T cell activation |
| GO:0040011 | 0.00019 | 1.75939 | 35 | 57 | 1977 | locomotion |
| GO:1901654 | 0.00019 | 3.73803 | 3 | 12 | 193 | response to ketone |
| GO:0002520 | 0.00019 | 2.07182 | 18 | 34 | 985 | immune system development |
| GO:0072593 | 0.00020 | 3.15816 | 5 | 15 | 284 | reactive oxygen species metabolic process |
| GO:0009887 | 0.00020 | 2.02560 | 19 | 36 | 1068 | animal organ morphogenesis |
| GO:0016584 | 0.00020 | 17.08438 | 0 | 4 | 17 | nucleosome positioning |
| GO:0061323 | 0.00020 | 17.08438 | 0 | 4 | 17 | cell proliferation involved in heart morphogenesis |
| GO:2000136 | 0.00020 | 17.08438 | 0 | 4 | 17 | regulation of cell proliferation involved in heart morphogenesis |
| GO:0043065 | 0.00020 | 2.31163 | 12 | 26 | 672 | positive regulation of apoptotic process |
| GO:0001656 | 0.00021 | 5.46282 | 2 | 8 | 90 | metanephros development |
| GO:0035924 | 0.00021 | 6.41325 | 1 | 7 | 68 | cellular response to vascular endothelial growth factor stimulus |
| GO:0015749 | 0.00021 | 4.80818 | 2 | 9 | 114 | monosaccharide transmembrane transport |
| GO:0042035 | 0.00021 | 4.80818 | 2 | 9 | 114 | regulation of cytokine biosynthetic process |
| GO:0072073 | 0.00022 | 4.32241 | 3 | 10 | 140 | kidney epithelium development |
| GO:0060538 | 0.00024 | 3.91813 | 3 | 11 | 169 | skeletal muscle organ development |
| GO:0034219 | 0.00024 | 4.71779 | 2 | 9 | 116 | carbohydrate transmembrane transport |
| GO:0051385 | 0.00024 | 10.30564 | 1 | 5 | 32 | response to mineralocorticoid |
| GO:0060674 | 0.00024 | 10.30564 | 1 | 5 | 32 | placenta blood vessel development |
| GO:1900745 | 0.00024 | 10.30564 | 1 | 5 | 32 | positive regulation of p38MAPK cascade |
| GO:0072006 | 0.00024 | 4.25645 | 3 | 10 | 142 | nephron development |
| GO:0062012 | 0.00024 | 2.59667 | 8 | 20 | 459 | regulation of small molecule metabolic process |
| GO:0007169 | 0.00025 | 2.24242 | 13 | 27 | 719 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0044093 | 0.00025 | 1.78251 | 32 | 52 | 1771 | positive regulation of molecular function |
| GO:0071396 | 0.00028 | 2.34504 | 11 | 24 | 610 | cellular response to lipid |
| GO:0050790 | 0.00028 | 1.68271 | 42 | 64 | 2328 | regulation of catalytic activity |
| GO:0007566 | 0.00029 | 7.43537 | 1 | 6 | 51 | embryo implantation |
| GO:0006334 | 0.00029 | 4.16118 | 3 | 10 | 145 | nucleosome assembly |
| GO:0007612 | 0.00029 | 4.16118 | 3 | 10 | 145 | learning |
| GO:0003018 | 0.00029 | 3.82055 | 3 | 11 | 173 | vascular process in circulatory system |
| GO:0000302 | 0.00029 | 3.35028 | 4 | 13 | 232 | response to reactive oxygen species |
| GO:0048511 | 0.00029 | 3.03224 | 5 | 15 | 295 | rhythmic process |
| GO:0019249 | 0.00030 | 33.22840 | 0 | 3 | 8 | lactate biosynthetic process |
| GO:0036490 | 0.00030 | 33.22840 | 0 | 3 | 8 | regulation of translation in response to endoplasmic reticulum stress |
| GO:0042492 | 0.00030 | 33.22840 | 0 | 3 | 8 | gamma-delta T cell differentiation |
| GO:0098532 | 0.00030 | 33.22840 | 0 | 3 | 8 | histone H3-K27 trimethylation |
| GO:0048608 | 0.00030 | 2.62410 | 8 | 19 | 431 | reproductive structure development |
| GO:0042542 | 0.00030 | 4.13036 | 3 | 10 | 146 | response to hydrogen peroxide |
| GO:0001655 | 0.00032 | 2.88779 | 6 | 16 | 330 | urogenital system development |
| GO:0061402 | 0.00032 | Inf | 0 | 2 | 2 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH |
| GO:0019217 | 0.00033 | 5.08868 | 2 | 8 | 96 | regulation of fatty acid metabolic process |
| GO:0061458 | 0.00033 | 2.60470 | 8 | 19 | 434 | reproductive system development |
| GO:0071216 | 0.00035 | 3.28945 | 4 | 13 | 236 | cellular response to biotic stimulus |
| GO:0001657 | 0.00035 | 5.03123 | 2 | 8 | 97 | ureteric bud development |
| GO:0120162 | 0.00035 | 5.03123 | 2 | 8 | 97 | positive regulation of cold-induced thermogenesis |
| GO:0006109 | 0.00035 | 3.48505 | 4 | 12 | 206 | regulation of carbohydrate metabolic process |
| GO:0032147 | 0.00035 | 2.85999 | 6 | 16 | 333 | activation of protein kinase activity |
| GO:0002043 | 0.00035 | 7.11819 | 1 | 6 | 53 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:1902475 | 0.00035 | 7.11819 | 1 | 6 | 53 | L-alpha-amino acid transmembrane transport |
| GO:0070373 | 0.00035 | 5.83701 | 1 | 7 | 74 | negative regulation of ERK1 and ERK2 cascade |
| GO:0014074 | 0.00036 | 4.04055 | 3 | 10 | 149 | response to purine-containing compound |
| GO:0031669 | 0.00036 | 3.27459 | 4 | 13 | 237 | cellular response to nutrient levels |
| GO:0042089 | 0.00037 | 4.42640 | 2 | 9 | 123 | cytokine biosynthetic process |
| GO:0001893 | 0.00037 | 9.27356 | 1 | 5 | 35 | maternal placenta development |
| GO:0072163 | 0.00038 | 4.97505 | 2 | 8 | 98 | mesonephric epithelium development |
| GO:0072164 | 0.00038 | 4.97505 | 2 | 8 | 98 | mesonephric tubule development |
| GO:0044267 | 0.00038 | 1.49134 | 94 | 123 | 5276 | cellular protein metabolic process |
| GO:0051247 | 0.00038 | 1.76512 | 31 | 50 | 1713 | positive regulation of protein metabolic process |
| GO:0045165 | 0.00038 | 3.08984 | 5 | 14 | 270 | cell fate commitment |
| GO:0031936 | 0.00039 | 13.87879 | 0 | 4 | 20 | negative regulation of chromatin silencing |
| GO:0033002 | 0.00039 | 3.24525 | 4 | 13 | 239 | muscle cell proliferation |
| GO:0042107 | 0.00039 | 4.38767 | 2 | 9 | 124 | cytokine metabolic process |
| GO:0051101 | 0.00039 | 4.38767 | 2 | 9 | 124 | regulation of DNA binding |
| GO:0007159 | 0.00040 | 2.82372 | 6 | 16 | 337 | leukocyte cell-cell adhesion |
| GO:0043405 | 0.00040 | 2.82372 | 6 | 16 | 337 | regulation of MAP kinase activity |
| GO:1903037 | 0.00040 | 2.93635 | 5 | 15 | 304 | regulation of leukocyte cell-cell adhesion |
| GO:0042327 | 0.00041 | 1.96073 | 19 | 35 | 1068 | positive regulation of phosphorylation |
| GO:1902105 | 0.00041 | 3.06555 | 5 | 14 | 272 | regulation of leukocyte differentiation |
| GO:0001890 | 0.00042 | 3.95453 | 3 | 10 | 152 | placenta development |
| GO:0010565 | 0.00043 | 3.63915 | 3 | 11 | 181 | regulation of cellular ketone metabolic process |
| GO:0043551 | 0.00043 | 6.82690 | 1 | 6 | 55 | regulation of phosphatidylinositol 3-kinase activity |
| GO:0003263 | 0.00044 | 27.68882 | 0 | 3 | 9 | cardioblast proliferation |
| GO:0097084 | 0.00044 | 27.68882 | 0 | 3 | 9 | vascular smooth muscle cell development |
| GO:0007517 | 0.00045 | 2.60747 | 7 | 18 | 410 | muscle organ development |
| GO:0043153 | 0.00047 | 13.06168 | 0 | 4 | 21 | entrainment of circadian clock by photoperiod |
| GO:0032502 | 0.00048 | 1.45956 | 115 | 144 | 6411 | developmental process |
| GO:0003156 | 0.00048 | 8.69301 | 1 | 5 | 37 | regulation of animal organ formation |
| GO:0045923 | 0.00048 | 8.69301 | 1 | 5 | 37 | positive regulation of fatty acid metabolic process |
| GO:1905314 | 0.00048 | 8.69301 | 1 | 5 | 37 | semi-lunar valve development |
| GO:0032879 | 0.00050 | 1.59329 | 51 | 74 | 2853 | regulation of localization |
| GO:0002066 | 0.00053 | 6.55846 | 1 | 6 | 57 | columnar/cuboidal epithelial cell development |
| GO:0048008 | 0.00053 | 6.55846 | 1 | 6 | 57 | platelet-derived growth factor receptor signaling pathway |
| GO:0071260 | 0.00053 | 5.43017 | 1 | 7 | 79 | cellular response to mechanical stimulus |
| GO:0042180 | 0.00055 | 3.11941 | 4 | 13 | 248 | cellular ketone metabolic process |
| GO:0097190 | 0.00056 | 2.26808 | 11 | 23 | 602 | apoptotic signaling pathway |
| GO:0019221 | 0.00056 | 2.08746 | 14 | 28 | 798 | cytokine-mediated signaling pathway |
| GO:0001817 | 0.00056 | 2.14913 | 13 | 26 | 719 | regulation of cytokine production |
| GO:0044342 | 0.00057 | 12.33535 | 0 | 4 | 22 | type B pancreatic cell proliferation |
| GO:0051093 | 0.00057 | 1.94011 | 19 | 34 | 1046 | negative regulation of developmental process |
| GO:0071560 | 0.00058 | 3.10602 | 4 | 13 | 249 | cellular response to transforming growth factor beta stimulus |
| GO:0071385 | 0.00058 | 6.43199 | 1 | 6 | 58 | cellular response to glucocorticoid stimulus |
| GO:0042692 | 0.00061 | 2.61843 | 7 | 17 | 385 | muscle cell differentiation |
| GO:0015801 | 0.00062 | 23.73198 | 0 | 3 | 10 | aromatic amino acid transport |
| GO:2000253 | 0.00062 | 23.73198 | 0 | 3 | 10 | positive regulation of feeding behavior |
| GO:0035886 | 0.00062 | 8.18076 | 1 | 5 | 39 | vascular smooth muscle cell differentiation |
| GO:0060969 | 0.00062 | 8.18076 | 1 | 5 | 39 | negative regulation of gene silencing |
| GO:2000826 | 0.00062 | 8.18076 | 1 | 5 | 39 | regulation of heart morphogenesis |
| GO:0003158 | 0.00062 | 4.10049 | 2 | 9 | 132 | endothelium development |
| GO:0070371 | 0.00062 | 2.80793 | 6 | 15 | 317 | ERK1 and ERK2 cascade |
| GO:0007519 | 0.00063 | 3.74198 | 3 | 10 | 160 | skeletal muscle tissue development |
| GO:0030098 | 0.00066 | 2.68727 | 6 | 16 | 353 | lymphocyte differentiation |
| GO:0006855 | 0.00066 | 5.21211 | 1 | 7 | 82 | drug transmembrane transport |
| GO:0090184 | 0.00070 | 7.94659 | 1 | 5 | 40 | positive regulation of kidney development |
| GO:0001934 | 0.00071 | 1.93331 | 18 | 33 | 1017 | positive regulation of protein phosphorylation |
| GO:0071559 | 0.00072 | 3.02801 | 5 | 13 | 255 | response to transforming growth factor beta |
| GO:0048568 | 0.00075 | 2.49049 | 8 | 18 | 428 | embryonic organ development |
| GO:0046649 | 0.00075 | 2.10490 | 13 | 26 | 733 | lymphocyte activation |
| GO:0071384 | 0.00076 | 6.08016 | 1 | 6 | 61 | cellular response to corticosteroid stimulus |
| GO:0072009 | 0.00077 | 4.43054 | 2 | 8 | 109 | nephron epithelium development |
| GO:0048468 | 0.00077 | 1.63758 | 39 | 59 | 2183 | cell development |
| GO:1902893 | 0.00079 | 7.72543 | 1 | 5 | 41 | regulation of pri-miRNA transcription by RNA polymerase II |
| GO:0031497 | 0.00079 | 3.62027 | 3 | 10 | 165 | chromatin assembly |
| GO:2000377 | 0.00080 | 3.35967 | 3 | 11 | 195 | regulation of reactive oxygen species metabolic process |
| GO:0009798 | 0.00082 | 5.01082 | 2 | 7 | 85 | axis specification |
| GO:0032835 | 0.00083 | 5.97125 | 1 | 6 | 62 | glomerulus development |
| GO:1905268 | 0.00083 | 5.97125 | 1 | 6 | 62 | negative regulation of chromatin organization |
| GO:0003264 | 0.00084 | 20.76435 | 0 | 3 | 11 | regulation of cardioblast proliferation |
| GO:0046677 | 0.00086 | 2.71642 | 6 | 15 | 327 | response to antibiotic |
| GO:0042149 | 0.00088 | 7.51622 | 1 | 5 | 42 | cellular response to glucose starvation |
| GO:0003333 | 0.00088 | 4.94712 | 2 | 7 | 86 | amino acid transmembrane transport |
| GO:0034637 | 0.00088 | 4.94712 | 2 | 7 | 86 | cellular carbohydrate biosynthetic process |
| GO:0045580 | 0.00090 | 3.87820 | 2 | 9 | 139 | regulation of T cell differentiation |
| GO:0007423 | 0.00092 | 2.26727 | 10 | 21 | 548 | sensory organ development |
| GO:0009648 | 0.00095 | 10.57143 | 0 | 4 | 25 | photoperiodism |
| GO:0072012 | 0.00095 | 10.57143 | 0 | 4 | 25 | glomerulus vasculature development |
| GO:0060086 | 0.00095 | 110.45181 | 0 | 2 | 3 | circadian temperature homeostasis |
| GO:0071409 | 0.00095 | 110.45181 | 0 | 2 | 3 | cellular response to cycloheximide |
| GO:0097532 | 0.00095 | 110.45181 | 0 | 2 | 3 | stress response to acid chemical |
| GO:0097533 | 0.00095 | 110.45181 | 0 | 2 | 3 | cellular stress response to acid chemical |
| GO:0048660 | 0.00095 | 3.52842 | 3 | 10 | 169 | regulation of smooth muscle cell proliferation |
| GO:0008202 | 0.00097 | 2.68144 | 6 | 15 | 331 | steroid metabolic process |
| GO:0032501 | 0.00097 | 1.41772 | 139 | 167 | 7751 | multicellular organismal process |
| GO:1903706 | 0.00098 | 2.36508 | 8 | 19 | 475 | regulation of hemopoiesis |
| GO:0043550 | 0.00098 | 5.76472 | 1 | 6 | 64 | regulation of lipid kinase activity |
| GO:0043433 | 0.00100 | 3.50617 | 3 | 10 | 170 | negative regulation of DNA-binding transcription factor activity |
| GO:0022407 | 0.00101 | 2.49383 | 7 | 17 | 403 | regulation of cell-cell adhesion |
| GO:0009791 | 0.00101 | 4.82444 | 2 | 7 | 88 | post-embryonic development |
| GO:0042752 | 0.00103 | 4.22040 | 2 | 8 | 114 | regulation of circadian rhythm |
| GO:1902533 | 0.00103 | 1.86957 | 19 | 34 | 1082 | positive regulation of intracellular signal transduction |
| GO:0001816 | 0.00103 | 2.02557 | 14 | 27 | 790 | cytokine production |
| GO:0048659 | 0.00104 | 3.48420 | 3 | 10 | 171 | smooth muscle cell proliferation |
| GO:0010675 | 0.00105 | 3.79010 | 3 | 9 | 142 | regulation of cellular carbohydrate metabolic process |
| GO:0035690 | 0.00106 | 2.56319 | 7 | 16 | 369 | cellular response to drug |
| GO:0070372 | 0.00107 | 2.76115 | 5 | 14 | 300 | regulation of ERK1 and ERK2 cascade |
| GO:0006928 | 0.00108 | 1.61178 | 40 | 59 | 2213 | movement of cell or subcellular component |
| GO:0006094 | 0.00108 | 4.76535 | 2 | 7 | 89 | gluconeogenesis |
| GO:0046427 | 0.00108 | 4.76535 | 2 | 7 | 89 | positive regulation of JAK-STAT cascade |
| GO:0060021 | 0.00108 | 4.76535 | 2 | 7 | 89 | roof of mouth development |
| GO:0002551 | 0.00111 | 18.45619 | 0 | 3 | 12 | mast cell chemotaxis |
| GO:0060213 | 0.00111 | 18.45619 | 0 | 3 | 12 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening |
| GO:0060670 | 0.00111 | 18.45619 | 0 | 3 | 12 | branching involved in labyrinthine layer morphogenesis |
| GO:0071468 | 0.00111 | 18.45619 | 0 | 3 | 12 | cellular response to acidic pH |
| GO:0097531 | 0.00111 | 18.45619 | 0 | 3 | 12 | mast cell migration |
| GO:0034599 | 0.00114 | 2.74167 | 5 | 14 | 302 | cellular response to oxidative stress |
| GO:0031018 | 0.00121 | 6.95137 | 1 | 5 | 45 | endocrine pancreas development |
| GO:0045581 | 0.00121 | 6.95137 | 1 | 5 | 45 | negative regulation of T cell differentiation |
| GO:0048871 | 0.00124 | 2.31303 | 9 | 19 | 485 | multicellular organismal homeostasis |
| GO:0015807 | 0.00125 | 5.48031 | 1 | 6 | 67 | L-amino acid transport |
| GO:0009649 | 0.00128 | 9.65112 | 0 | 4 | 27 | entrainment of circadian clock |
| GO:0061437 | 0.00128 | 9.65112 | 0 | 4 | 27 | renal system vasculature development |
| GO:0061440 | 0.00128 | 9.65112 | 0 | 4 | 27 | kidney vasculature development |
| GO:0045834 | 0.00128 | 3.67863 | 3 | 9 | 146 | positive regulation of lipid metabolic process |
| GO:0070555 | 0.00130 | 3.15189 | 4 | 11 | 207 | response to interleukin-1 |
| GO:0019319 | 0.00131 | 4.59640 | 2 | 7 | 92 | hexose biosynthetic process |
| GO:1904894 | 0.00131 | 4.59640 | 2 | 7 | 92 | positive regulation of STAT cascade |
| GO:0005978 | 0.00134 | 6.78145 | 1 | 5 | 46 | glycogen biosynthetic process |
| GO:0006984 | 0.00134 | 6.78145 | 1 | 5 | 46 | ER-nucleus signaling pathway |
| GO:0009250 | 0.00134 | 6.78145 | 1 | 5 | 46 | glucan biosynthetic process |
| GO:0060711 | 0.00134 | 6.78145 | 1 | 5 | 46 | labyrinthine layer development |
| GO:1903587 | 0.00134 | 6.78145 | 1 | 5 | 46 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:0048469 | 0.00135 | 3.35791 | 3 | 10 | 177 | cell maturation |
| GO:0017148 | 0.00141 | 3.11971 | 4 | 11 | 209 | negative regulation of translation |
| GO:0071229 | 0.00141 | 3.11971 | 4 | 11 | 209 | cellular response to acid chemical |
| GO:0009790 | 0.00142 | 1.86651 | 18 | 32 | 1017 | embryo development |
| GO:0010763 | 0.00142 | 16.60967 | 0 | 3 | 13 | positive regulation of fibroblast migration |
| GO:0060712 | 0.00142 | 16.60967 | 0 | 3 | 13 | spongiotrophoblast layer development |
| GO:0061029 | 0.00142 | 16.60967 | 0 | 3 | 13 | eyelid development in camera-type eye |
| GO:0065008 | 0.00144 | 1.46385 | 73 | 96 | 4057 | regulation of biological quality |
| GO:0048520 | 0.00147 | 9.24848 | 1 | 4 | 28 | positive regulation of behavior |
| GO:0017144 | 0.00147 | 1.94714 | 15 | 28 | 851 | drug metabolic process |
| GO:0071347 | 0.00147 | 3.31781 | 3 | 10 | 179 | cellular response to interleukin-1 |
| GO:0030968 | 0.00151 | 3.95744 | 2 | 8 | 121 | endoplasmic reticulum unfolded protein response |
| GO:0045860 | 0.00153 | 2.21736 | 10 | 20 | 532 | positive regulation of protein kinase activity |
| GO:0019538 | 0.00154 | 1.41122 | 107 | 133 | 5986 | protein metabolic process |
| GO:0060324 | 0.00162 | 6.46533 | 1 | 5 | 48 | face development |
| GO:0061014 | 0.00162 | 6.46533 | 1 | 5 | 48 | positive regulation of mRNA catabolic process |
| GO:0007178 | 0.00164 | 2.53440 | 6 | 15 | 349 | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0061138 | 0.00167 | 3.25940 | 3 | 10 | 182 | morphogenesis of a branching epithelium |
| GO:1990823 | 0.00168 | 4.38886 | 2 | 7 | 96 | response to leukemia inhibitory factor |
| GO:1990830 | 0.00168 | 4.38886 | 2 | 7 | 96 | cellular response to leukemia inhibitory factor |
| GO:0031098 | 0.00170 | 2.62137 | 6 | 14 | 315 | stress-activated protein kinase signaling cascade |
| GO:0040007 | 0.00170 | 1.86205 | 18 | 31 | 986 | growth |
| GO:0019218 | 0.00176 | 3.85445 | 2 | 8 | 124 | regulation of steroid metabolic process |
| GO:0065004 | 0.00177 | 2.85820 | 4 | 12 | 248 | protein-DNA complex assembly |
| GO:0060211 | 0.00178 | 15.09887 | 0 | 3 | 14 | regulation of nuclear-transcribed mRNA poly(A) tail shortening |
| GO:0048584 | 0.00180 | 1.54716 | 45 | 64 | 2500 | positive regulation of response to stimulus |
| GO:0034728 | 0.00181 | 3.22158 | 3 | 10 | 184 | nucleosome organization |
| GO:0035019 | 0.00182 | 5.06375 | 1 | 6 | 72 | somatic stem cell population maintenance |
| GO:0060193 | 0.00182 | 5.06375 | 1 | 6 | 72 | positive regulation of lipase activity |
| GO:0032270 | 0.00184 | 1.66746 | 29 | 45 | 1611 | positive regulation of cellular protein metabolic process |
| GO:0046898 | 0.00187 | 55.22289 | 0 | 2 | 4 | response to cycloheximide |
| GO:0060708 | 0.00187 | 55.22289 | 0 | 2 | 4 | spongiotrophoblast differentiation |
| GO:0061009 | 0.00187 | 55.22289 | 0 | 2 | 4 | common bile duct development |
| GO:0089709 | 0.00187 | 55.22289 | 0 | 2 | 4 | L-histidine transmembrane transport |
| GO:0097167 | 0.00187 | 55.22289 | 0 | 2 | 4 | circadian regulation of translation |
| GO:1904612 | 0.00187 | 55.22289 | 0 | 2 | 4 | response to 2,3,7,8-tetrachlorodibenzodioxine |
| GO:2000182 | 0.00187 | 55.22289 | 0 | 2 | 4 | regulation of progesterone biosynthetic process |
| GO:0003012 | 0.00189 | 2.27963 | 8 | 18 | 465 | muscle system process |
| GO:0046364 | 0.00190 | 4.29193 | 2 | 7 | 98 | monosaccharide biosynthetic process |
| GO:0060191 | 0.00190 | 4.29193 | 2 | 7 | 98 | regulation of lipase activity |
| GO:1903707 | 0.00193 | 3.45016 | 3 | 9 | 155 | negative regulation of hemopoiesis |
| GO:0051726 | 0.00198 | 1.76117 | 22 | 36 | 1213 | regulation of cell cycle |
| GO:0051403 | 0.00202 | 2.67957 | 5 | 13 | 286 | stress-activated MAPK cascade |
| GO:0071375 | 0.00202 | 2.56928 | 6 | 14 | 321 | cellular response to peptide hormone stimulus |
| GO:0050794 | 0.00204 | 1.40216 | 197 | 223 | 11022 | regulation of cellular process |
| GO:0035270 | 0.00205 | 3.75666 | 2 | 8 | 127 | endocrine system development |
| GO:0043410 | 0.00207 | 2.15664 | 10 | 20 | 546 | positive regulation of MAPK cascade |
| GO:0005977 | 0.00209 | 4.91428 | 1 | 6 | 74 | glycogen metabolic process |
| GO:0051145 | 0.00209 | 4.91428 | 1 | 6 | 74 | smooth muscle cell differentiation |
| GO:2000027 | 0.00209 | 2.79812 | 5 | 12 | 253 | regulation of animal organ morphogenesis |
| GO:0032007 | 0.00213 | 6.04269 | 1 | 5 | 51 | negative regulation of TOR signaling |
| GO:1902895 | 0.00216 | 8.21953 | 1 | 4 | 31 | positive regulation of pri-miRNA transcription by RNA polymerase II |
| GO:0032352 | 0.00220 | 13.83988 | 0 | 3 | 15 | positive regulation of hormone metabolic process |
| GO:0042976 | 0.00220 | 13.83988 | 0 | 3 | 15 | activation of Janus kinase activity |
| GO:0046321 | 0.00220 | 13.83988 | 0 | 3 | 15 | positive regulation of fatty acid oxidation |
| GO:0006073 | 0.00224 | 4.84279 | 1 | 6 | 75 | cellular glucan metabolic process |
| GO:0044042 | 0.00224 | 4.84279 | 1 | 6 | 75 | glucan metabolic process |
| GO:0007631 | 0.00225 | 4.15427 | 2 | 7 | 101 | feeding behavior |
| GO:0034440 | 0.00225 | 4.15427 | 2 | 7 | 101 | lipid oxidation |
| GO:0007611 | 0.00231 | 2.76326 | 5 | 12 | 256 | learning or memory |
| GO:0003179 | 0.00232 | 5.91379 | 1 | 5 | 52 | heart valve morphogenesis |
| GO:0006333 | 0.00238 | 3.09580 | 3 | 10 | 191 | chromatin assembly or disassembly |
| GO:2000379 | 0.00238 | 4.11032 | 2 | 7 | 102 | positive regulation of reactive oxygen species metabolic process |
| GO:0051241 | 0.00240 | 1.71352 | 24 | 38 | 1316 | negative regulation of multicellular organismal process |
| GO:0001569 | 0.00244 | 7.92554 | 1 | 4 | 32 | branching involved in blood vessel morphogenesis |
| GO:0003176 | 0.00244 | 7.92554 | 1 | 4 | 32 | aortic valve development |
| GO:0003338 | 0.00244 | 7.92554 | 1 | 4 | 32 | metanephros morphogenesis |
| GO:0046685 | 0.00244 | 7.92554 | 1 | 4 | 32 | response to arsenic-containing substance |
| GO:0050779 | 0.00244 | 7.92554 | 1 | 4 | 32 | RNA destabilization |
| GO:0060325 | 0.00244 | 7.92554 | 1 | 4 | 32 | face morphogenesis |
| GO:0006629 | 0.00244 | 1.68889 | 25 | 40 | 1407 | lipid metabolic process |
| GO:1902106 | 0.00252 | 4.06728 | 2 | 7 | 103 | negative regulation of leukocyte differentiation |
| GO:0061418 | 0.00256 | 4.70586 | 1 | 6 | 77 | regulation of transcription from RNA polymerase II promoter in response to hypoxia |
| GO:0007219 | 0.00256 | 3.06163 | 3 | 10 | 193 | Notch signaling pathway |
| GO:0061158 | 0.00267 | 12.77458 | 0 | 3 | 16 | 3'-UTR-mediated mRNA destabilization |
| GO:0072109 | 0.00267 | 12.77458 | 0 | 3 | 16 | glomerular mesangium development |
| GO:0080182 | 0.00267 | 12.77458 | 0 | 3 | 16 | histone H3-K4 trimethylation |
| GO:0051091 | 0.00270 | 2.70703 | 5 | 12 | 261 | positive regulation of DNA-binding transcription factor activity |
| GO:0010827 | 0.00273 | 4.64024 | 1 | 6 | 78 | regulation of glucose transmembrane transport |
| GO:0002763 | 0.00274 | 5.67179 | 1 | 5 | 54 | positive regulation of myeloid leukocyte differentiation |
| GO:0045747 | 0.00274 | 5.67179 | 1 | 5 | 54 | positive regulation of Notch signaling pathway |
| GO:0061005 | 0.00274 | 5.67179 | 1 | 5 | 54 | cell differentiation involved in kidney development |
| GO:0031401 | 0.00275 | 1.72356 | 22 | 36 | 1237 | positive regulation of protein modification process |
| GO:0008593 | 0.00281 | 3.98384 | 2 | 7 | 105 | regulation of Notch signaling pathway |
| GO:0034248 | 0.00284 | 2.18918 | 9 | 18 | 483 | regulation of cellular amide metabolic process |
| GO:0001763 | 0.00286 | 3.01175 | 4 | 10 | 196 | morphogenesis of a branching structure |
| GO:0044283 | 0.00287 | 1.89746 | 14 | 26 | 807 | small molecule biosynthetic process |
| GO:0034249 | 0.00287 | 2.83037 | 4 | 11 | 229 | negative regulation of cellular amide metabolic process |
| GO:0009894 | 0.00295 | 1.80803 | 18 | 30 | 979 | regulation of catabolic process |
| GO:0071695 | 0.00295 | 3.22722 | 3 | 9 | 165 | anatomical structure maturation |
| GO:0051249 | 0.00297 | 2.17956 | 9 | 18 | 485 | regulation of lymphocyte activation |
| GO:0045620 | 0.00297 | 5.55805 | 1 | 5 | 55 | negative regulation of lymphocyte differentiation |
| GO:0001889 | 0.00300 | 3.51848 | 2 | 8 | 135 | liver development |
| GO:0006003 | 0.00308 | 36.81325 | 0 | 2 | 5 | fructose 2,6-bisphosphate metabolic process |
| GO:0045586 | 0.00308 | 36.81325 | 0 | 2 | 5 | regulation of gamma-delta T cell differentiation |
| GO:0071504 | 0.00308 | 36.81325 | 0 | 2 | 5 | cellular response to heparin |
| GO:1902714 | 0.00308 | 36.81325 | 0 | 2 | 5 | negative regulation of interferon-gamma secretion |
| GO:1903898 | 0.00308 | 36.81325 | 0 | 2 | 5 | negative regulation of PERK-mediated unfolded protein response |
| GO:0046890 | 0.00308 | 2.97938 | 4 | 10 | 198 | regulation of lipid biosynthetic process |
| GO:0035051 | 0.00319 | 3.18602 | 3 | 9 | 167 | cardiocyte differentiation |
| GO:0007179 | 0.00319 | 2.96345 | 4 | 10 | 199 | transforming growth factor beta receptor signaling pathway |
| GO:0006089 | 0.00320 | 11.86146 | 0 | 3 | 17 | lactate metabolic process |
| GO:0090183 | 0.00322 | 5.44878 | 1 | 5 | 56 | regulation of kidney development |
| GO:0048738 | 0.00328 | 2.77876 | 4 | 11 | 233 | cardiac muscle tissue development |
| GO:0097305 | 0.00328 | 2.77876 | 4 | 11 | 233 | response to alcohol |
| GO:0007045 | 0.00330 | 4.45390 | 1 | 6 | 81 | cell-substrate adherens junction assembly |
| GO:0048041 | 0.00330 | 4.45390 | 1 | 6 | 81 | focal adhesion assembly |
| GO:0110110 | 0.00330 | 4.45390 | 1 | 6 | 81 | positive regulation of animal organ morphogenesis |
| GO:0061008 | 0.00343 | 3.43672 | 2 | 8 | 138 | hepaticobiliary system development |
| GO:0002694 | 0.00344 | 2.05590 | 10 | 20 | 571 | regulation of leukocyte activation |
| GO:0045619 | 0.00345 | 3.14585 | 3 | 9 | 169 | regulation of lymphocyte differentiation |
| GO:0014897 | 0.00346 | 3.82677 | 2 | 7 | 109 | striated muscle hypertrophy |
| GO:0046777 | 0.00350 | 2.75365 | 4 | 11 | 235 | protein autophosphorylation |
| GO:0030099 | 0.00353 | 2.25610 | 7 | 16 | 416 | myeloid cell differentiation |
| GO:0033674 | 0.00358 | 2.04824 | 10 | 20 | 573 | positive regulation of kinase activity |
| GO:0042509 | 0.00373 | 4.33774 | 1 | 6 | 83 | regulation of tyrosine phosphorylation of STAT protein |
| GO:0003205 | 0.00373 | 3.10667 | 3 | 9 | 171 | cardiac chamber development |
| GO:0034620 | 0.00374 | 3.38427 | 3 | 8 | 140 | cellular response to unfolded protein |
| GO:0019229 | 0.00375 | 5.24259 | 1 | 5 | 58 | regulation of vasoconstriction |
| GO:0043555 | 0.00379 | 11.07009 | 0 | 3 | 18 | regulation of translation in response to stress |
| GO:0072311 | 0.00379 | 11.07009 | 0 | 3 | 18 | glomerular epithelial cell differentiation |
| GO:1900153 | 0.00379 | 11.07009 | 0 | 3 | 18 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
| GO:0002573 | 0.00381 | 2.88628 | 4 | 10 | 204 | myeloid leukocyte differentiation |
| GO:0035265 | 0.00381 | 2.88628 | 4 | 10 | 204 | organ growth |
| GO:0014896 | 0.00382 | 3.75276 | 2 | 7 | 111 | muscle hypertrophy |
| GO:0030258 | 0.00385 | 2.71681 | 4 | 11 | 238 | lipid modification |
| GO:0055114 | 0.00394 | 1.76868 | 18 | 30 | 999 | oxidation-reduction process |
| GO:0002065 | 0.00402 | 3.71682 | 2 | 7 | 112 | columnar/cuboidal epithelial cell differentiation |
| GO:0003279 | 0.00402 | 3.71682 | 2 | 7 | 112 | cardiac septum development |
| GO:0010518 | 0.00404 | 5.14522 | 1 | 5 | 59 | positive regulation of phospholipase activity |
| GO:0043388 | 0.00404 | 5.14522 | 1 | 5 | 59 | positive regulation of DNA binding |
| GO:0031329 | 0.00404 | 1.82273 | 16 | 27 | 871 | regulation of cellular catabolic process |
| GO:0031935 | 0.00417 | 6.72287 | 1 | 4 | 37 | regulation of chromatin silencing |
| GO:0033280 | 0.00417 | 6.72287 | 1 | 4 | 37 | response to vitamin D |
| GO:0034405 | 0.00417 | 6.72287 | 1 | 4 | 37 | response to fluid shear stress |
| GO:0060323 | 0.00417 | 6.72287 | 1 | 4 | 37 | head morphogenesis |
| GO:0009607 | 0.00418 | 1.74411 | 19 | 31 | 1047 | response to biotic stimulus |
| GO:0006417 | 0.00424 | 2.21088 | 8 | 16 | 424 | regulation of translation |
| GO:0009967 | 0.00430 | 1.58520 | 30 | 45 | 1685 | positive regulation of signal transduction |
| GO:0030218 | 0.00443 | 3.64695 | 2 | 7 | 114 | erythrocyte differentiation |
| GO:1902107 | 0.00444 | 3.28401 | 3 | 8 | 144 | positive regulation of leukocyte differentiation |
| GO:0007260 | 0.00444 | 4.17439 | 2 | 6 | 86 | tyrosine phosphorylation of STAT protein |
| GO:0060716 | 0.00444 | 10.37764 | 0 | 3 | 19 | labyrinthine layer blood vessel development |
| GO:0071243 | 0.00444 | 10.37764 | 0 | 3 | 19 | cellular response to arsenic-containing substance |
| GO:0043010 | 0.00448 | 2.42654 | 6 | 13 | 314 | camera-type eye development |
| GO:0006986 | 0.00451 | 3.01282 | 3 | 9 | 176 | response to unfolded protein |
| GO:0031394 | 0.00456 | 27.60843 | 0 | 2 | 6 | positive regulation of prostaglandin biosynthetic process |
| GO:0032792 | 0.00456 | 27.60843 | 0 | 2 | 6 | negative regulation of CREB transcription factor activity |
| GO:0050917 | 0.00456 | 27.60843 | 0 | 2 | 6 | sensory perception of umami taste |
| GO:0060754 | 0.00456 | 27.60843 | 0 | 2 | 6 | positive regulation of mast cell chemotaxis |
| GO:0071503 | 0.00456 | 27.60843 | 0 | 2 | 6 | response to heparin |
| GO:0072126 | 0.00456 | 27.60843 | 0 | 2 | 6 | positive regulation of glomerular mesangial cell proliferation |
| GO:0097411 | 0.00456 | 27.60843 | 0 | 2 | 6 | hypoxia-inducible factor-1alpha signaling pathway |
| GO:2000138 | 0.00456 | 27.60843 | 0 | 2 | 6 | positive regulation of cell proliferation involved in heart morphogenesis |
| GO:2000323 | 0.00456 | 27.60843 | 0 | 2 | 6 | negative regulation of glucocorticoid receptor signaling pathway |
| GO:0048598 | 0.00458 | 1.99973 | 10 | 20 | 586 | embryonic morphogenesis |
| GO:0032350 | 0.00460 | 6.52478 | 1 | 4 | 38 | regulation of hormone metabolic process |
| GO:0006865 | 0.00462 | 3.25986 | 3 | 8 | 145 | amino acid transport |
| GO:0048645 | 0.00466 | 4.96092 | 1 | 5 | 61 | animal organ formation |
| GO:0006323 | 0.00467 | 2.79877 | 4 | 10 | 210 | DNA packaging |
| GO:0001892 | 0.00470 | 4.12263 | 2 | 6 | 87 | embryonic placenta development |
| GO:0006112 | 0.00470 | 4.12263 | 2 | 6 | 87 | energy reserve metabolic process |
| GO:1903725 | 0.00497 | 4.07213 | 2 | 6 | 88 | regulation of phospholipid metabolic process |
| GO:0071219 | 0.00499 | 2.77075 | 4 | 10 | 212 | cellular response to molecule of bacterial origin |
| GO:0006325 | 0.00505 | 1.83328 | 14 | 25 | 800 | chromatin organization |
| GO:0097237 | 0.00508 | 2.61190 | 4 | 11 | 247 | cellular response to toxic substance |
| GO:0010906 | 0.00510 | 3.54690 | 2 | 7 | 117 | regulation of glucose metabolic process |
| GO:0048745 | 0.00516 | 9.76666 | 0 | 3 | 20 | smooth muscle tissue development |
| GO:0072234 | 0.00516 | 9.76666 | 0 | 3 | 20 | metanephric nephron tubule development |
| GO:1900151 | 0.00516 | 9.76666 | 0 | 3 | 20 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
| GO:0043085 | 0.00519 | 1.61804 | 25 | 39 | 1424 | positive regulation of catalytic activity |
| GO:0048732 | 0.00528 | 2.15678 | 8 | 16 | 434 | gland development |
| GO:0021700 | 0.00530 | 2.47497 | 5 | 12 | 284 | developmental maturation |
| GO:0007610 | 0.00531 | 1.97097 | 11 | 20 | 594 | behavior |
| GO:0007399 | 0.00537 | 1.48403 | 42 | 59 | 2375 | nervous system development |
| GO:0007568 | 0.00538 | 2.37047 | 6 | 13 | 321 | aging |
| GO:0006352 | 0.00539 | 2.58967 | 4 | 11 | 249 | DNA-templated transcription, initiation |
| GO:0022414 | 0.00549 | 1.61174 | 26 | 39 | 1429 | reproductive process |
| GO:0042036 | 0.00554 | 6.16162 | 1 | 4 | 40 | negative regulation of cytokine biosynthetic process |
| GO:0072210 | 0.00554 | 6.16162 | 1 | 4 | 40 | metanephric nephron development |
| GO:0034333 | 0.00554 | 3.97474 | 2 | 6 | 90 | adherens junction assembly |
| GO:0001503 | 0.00560 | 2.20414 | 7 | 15 | 398 | ossification |
| GO:0000003 | 0.00568 | 1.60798 | 26 | 39 | 1432 | reproduction |
| GO:0045600 | 0.00572 | 4.70790 | 1 | 5 | 64 | positive regulation of fat cell differentiation |
| GO:0060135 | 0.00572 | 4.70790 | 1 | 5 | 64 | maternal process involved in female pregnancy |
| GO:0045639 | 0.00585 | 3.92776 | 2 | 6 | 91 | positive regulation of myeloid cell differentiation |
| GO:0001654 | 0.00588 | 2.26142 | 6 | 14 | 362 | eye development |
| GO:0071824 | 0.00591 | 2.43856 | 5 | 12 | 288 | protein-DNA complex subunit organization |
| GO:0055093 | 0.00594 | 9.22356 | 0 | 3 | 21 | response to hyperoxia |
| GO:0060713 | 0.00594 | 9.22356 | 0 | 3 | 21 | labyrinthine layer morphogenesis |
| GO:0070734 | 0.00594 | 9.22356 | 0 | 3 | 21 | histone H3-K27 methylation |
| GO:0071498 | 0.00594 | 9.22356 | 0 | 3 | 21 | cellular response to fluid shear stress |
| GO:0072010 | 0.00594 | 9.22356 | 0 | 3 | 21 | glomerular epithelium development |
| GO:2000738 | 0.00594 | 9.22356 | 0 | 3 | 21 | positive regulation of stem cell differentiation |
| GO:0043401 | 0.00600 | 2.87383 | 3 | 9 | 184 | steroid hormone mediated signaling pathway |
| GO:0022008 | 0.00603 | 1.56707 | 29 | 43 | 1623 | neurogenesis |
| GO:0007162 | 0.00607 | 2.42963 | 5 | 12 | 289 | negative regulation of cell adhesion |
| GO:0097193 | 0.00607 | 2.42963 | 5 | 12 | 289 | intrinsic apoptotic signaling pathway |
| GO:0051187 | 0.00611 | 4.62918 | 1 | 5 | 65 | cofactor catabolic process |
| GO:1903708 | 0.00621 | 2.85734 | 3 | 9 | 185 | positive regulation of hemopoiesis |
| GO:0010035 | 0.00624 | 1.97648 | 10 | 19 | 562 | response to inorganic substance |
| GO:0045785 | 0.00625 | 2.17513 | 7 | 15 | 403 | positive regulation of cell adhesion |
| GO:0006701 | 0.00631 | 22.08554 | 0 | 2 | 7 | progesterone biosynthetic process |
| GO:0032762 | 0.00631 | 22.08554 | 0 | 2 | 7 | mast cell cytokine production |
| GO:0035795 | 0.00631 | 22.08554 | 0 | 2 | 7 | negative regulation of mitochondrial membrane permeability |
| GO:0036491 | 0.00631 | 22.08554 | 0 | 2 | 7 | regulation of translation initiation in response to endoplasmic reticulum stress |
| GO:0060753 | 0.00631 | 22.08554 | 0 | 2 | 7 | regulation of mast cell chemotaxis |
| GO:0034101 | 0.00639 | 3.39176 | 2 | 7 | 122 | erythrocyte homeostasis |
| GO:0150063 | 0.00645 | 2.23523 | 7 | 14 | 366 | visual system development |
| GO:0046634 | 0.00649 | 3.83705 | 2 | 6 | 93 | regulation of alpha-beta T cell activation |
| GO:1901655 | 0.00649 | 3.83705 | 2 | 6 | 93 | cellular response to ketone |
| GO:0042592 | 0.00663 | 1.51661 | 34 | 49 | 1916 | homeostatic process |
| GO:0044282 | 0.00666 | 2.10019 | 8 | 16 | 445 | small molecule catabolic process |
| GO:0051146 | 0.00674 | 2.39451 | 5 | 12 | 293 | striated muscle cell differentiation |
| GO:0051347 | 0.00674 | 1.89184 | 12 | 21 | 649 | positive regulation of transferase activity |
| GO:0019752 | 0.00675 | 1.68092 | 19 | 31 | 1083 | carboxylic acid metabolic process |
| GO:0010884 | 0.00679 | 8.73764 | 0 | 3 | 22 | positive regulation of lipid storage |
| GO:0060487 | 0.00679 | 8.73764 | 0 | 3 | 22 | lung epithelial cell differentiation |
| GO:1903589 | 0.00679 | 8.73764 | 0 | 3 | 22 | positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:0007389 | 0.00680 | 2.09519 | 8 | 16 | 446 | pattern specification process |
| GO:0006091 | 0.00680 | 1.99905 | 9 | 18 | 526 | generation of precursor metabolites and energy |
| GO:0051289 | 0.00683 | 3.79324 | 2 | 6 | 94 | protein homotetramerization |
| GO:0060993 | 0.00683 | 3.79324 | 2 | 6 | 94 | kidney morphogenesis |
| GO:1901216 | 0.00683 | 3.79324 | 2 | 6 | 94 | positive regulation of neuron death |
| GO:0006367 | 0.00688 | 2.80899 | 3 | 9 | 188 | transcription initiation from RNA polymerase II promoter |
| GO:0030858 | 0.00694 | 4.47936 | 1 | 5 | 67 | positive regulation of epithelial cell differentiation |
| GO:0042108 | 0.00694 | 4.47936 | 1 | 5 | 67 | positive regulation of cytokine biosynthetic process |
| GO:0046365 | 0.00694 | 4.47936 | 1 | 5 | 67 | monosaccharide catabolic process |
| GO:0032787 | 0.00697 | 1.88562 | 12 | 21 | 651 | monocarboxylic acid metabolic process |
| GO:0043406 | 0.00697 | 2.49407 | 5 | 11 | 258 | positive regulation of MAP kinase activity |
| GO:0007265 | 0.00708 | 2.08526 | 8 | 16 | 448 | Ras protein signal transduction |
| GO:0010863 | 0.00717 | 5.68671 | 1 | 4 | 43 | positive regulation of phospholipase C activity |
| GO:0051602 | 0.00717 | 5.68671 | 1 | 4 | 43 | response to electrical stimulus |
| GO:0071364 | 0.00717 | 5.68671 | 1 | 4 | 43 | cellular response to epidermal growth factor stimulus |
| GO:0044070 | 0.00719 | 3.75041 | 2 | 6 | 95 | regulation of anion transport |
| GO:0051196 | 0.00719 | 3.75041 | 2 | 6 | 95 | regulation of coenzyme metabolic process |
| GO:0010817 | 0.00719 | 1.98698 | 9 | 18 | 529 | regulation of hormone levels |
| GO:0048880 | 0.00723 | 2.20331 | 7 | 14 | 371 | sensory system development |
| GO:0050890 | 0.00728 | 2.36882 | 5 | 12 | 296 | cognition |
| GO:0046323 | 0.00739 | 4.40802 | 1 | 5 | 68 | glucose import |
| GO:0019827 | 0.00739 | 2.99535 | 3 | 8 | 157 | stem cell population maintenance |
| GO:1901564 | 0.00741 | 1.32124 | 126 | 148 | 7040 | organonitrogen compound metabolic process |
| GO:0050865 | 0.00755 | 1.90246 | 11 | 20 | 614 | regulation of cell activation |
| GO:0051098 | 0.00757 | 2.19079 | 7 | 14 | 373 | regulation of binding |
| GO:0046031 | 0.00759 | 3.27703 | 2 | 7 | 126 | ADP metabolic process |
| GO:0043467 | 0.00767 | 2.97521 | 3 | 8 | 158 | regulation of generation of precursor metabolites and energy |
| GO:0007530 | 0.00771 | 8.30030 | 0 | 3 | 23 | sex determination |
| GO:0010447 | 0.00771 | 8.30030 | 0 | 3 | 23 | response to acidic pH |
| GO:0060479 | 0.00771 | 8.30030 | 0 | 3 | 23 | lung cell differentiation |
| GO:0071467 | 0.00771 | 8.30030 | 0 | 3 | 23 | cellular response to pH |
| GO:0072170 | 0.00771 | 8.30030 | 0 | 3 | 23 | metanephric tubule development |
| GO:0072243 | 0.00771 | 8.30030 | 0 | 3 | 23 | metanephric nephron epithelium development |
| GO:0035850 | 0.00778 | 5.54424 | 1 | 4 | 44 | epithelial cell differentiation involved in kidney development |
| GO:0045910 | 0.00778 | 5.54424 | 1 | 4 | 44 | negative regulation of DNA recombination |
| GO:0007044 | 0.00794 | 3.66758 | 2 | 6 | 97 | cell-substrate junction assembly |
| GO:0098727 | 0.00795 | 2.95535 | 3 | 8 | 159 | maintenance of cell number |
| GO:0010647 | 0.00831 | 1.50722 | 33 | 47 | 1844 | positive regulation of cell communication |
| GO:0007155 | 0.00831 | 1.57491 | 25 | 38 | 1420 | cell adhesion |
| GO:0001955 | 0.00832 | 18.40361 | 0 | 2 | 8 | blood vessel maturation |
| GO:0009750 | 0.00832 | 18.40361 | 0 | 2 | 8 | response to fructose |
| GO:0030853 | 0.00832 | 18.40361 | 0 | 2 | 8 | negative regulation of granulocyte differentiation |
| GO:0060534 | 0.00832 | 18.40361 | 0 | 2 | 8 | trachea cartilage development |
| GO:0061476 | 0.00832 | 18.40361 | 0 | 2 | 8 | response to anticoagulant |
| GO:0071499 | 0.00832 | 18.40361 | 0 | 2 | 8 | cellular response to laminar fluid shear stress |
| GO:0072282 | 0.00832 | 18.40361 | 0 | 2 | 8 | metanephric nephron tubule morphogenesis |
| GO:0090400 | 0.00832 | 18.40361 | 0 | 2 | 8 | stress-induced premature senescence |
| GO:1901724 | 0.00832 | 18.40361 | 0 | 2 | 8 | positive regulation of cell proliferation involved in kidney development |
| GO:2000020 | 0.00832 | 18.40361 | 0 | 2 | 8 | positive regulation of male gonad development |
| GO:2000322 | 0.00832 | 18.40361 | 0 | 2 | 8 | regulation of glucocorticoid receptor signaling pathway |
| GO:2001016 | 0.00832 | 18.40361 | 0 | 2 | 8 | positive regulation of skeletal muscle cell differentiation |
| GO:2001280 | 0.00832 | 18.40361 | 0 | 2 | 8 | positive regulation of unsaturated fatty acid biosynthetic process |
| GO:0010517 | 0.00833 | 4.27192 | 1 | 5 | 70 | regulation of phospholipase activity |
| GO:0060395 | 0.00833 | 4.27192 | 1 | 5 | 70 | SMAD protein signal transduction |
| GO:0072091 | 0.00833 | 4.27192 | 1 | 5 | 70 | regulation of stem cell proliferation |
| GO:0032570 | 0.00842 | 5.40872 | 1 | 4 | 45 | response to progesterone |
| GO:1900274 | 0.00842 | 5.40872 | 1 | 4 | 45 | regulation of phospholipase C activity |
| GO:0006082 | 0.00851 | 1.62484 | 21 | 33 | 1192 | organic acid metabolic process |
| GO:0035967 | 0.00854 | 2.91640 | 3 | 8 | 161 | cellular response to topologically incorrect protein |
| GO:0003206 | 0.00859 | 3.19592 | 2 | 7 | 129 | cardiac chamber morphogenesis |
| GO:1903038 | 0.00859 | 3.19592 | 2 | 7 | 129 | negative regulation of leukocyte cell-cell adhesion |
| GO:0046835 | 0.00869 | 7.90462 | 0 | 3 | 24 | carbohydrate phosphorylation |
| GO:0019395 | 0.00874 | 3.58832 | 2 | 6 | 99 | fatty acid oxidation |
| GO:0033692 | 0.00884 | 4.20696 | 1 | 5 | 71 | cellular polysaccharide biosynthetic process |
| GO:0042531 | 0.00884 | 4.20696 | 1 | 5 | 71 | positive regulation of tyrosine phosphorylation of STAT protein |
| GO:0050795 | 0.00884 | 4.20696 | 1 | 5 | 71 | regulation of behavior |
| GO:0023056 | 0.00888 | 1.50074 | 33 | 47 | 1851 | positive regulation of signaling |
| GO:0006694 | 0.00893 | 2.68763 | 4 | 9 | 196 | steroid biosynthetic process |
| GO:0003231 | 0.00894 | 3.16976 | 2 | 7 | 130 | cardiac ventricle development |
| GO:0022610 | 0.00897 | 1.56633 | 26 | 38 | 1427 | biological adhesion |
| GO:0044703 | 0.00901 | 1.67130 | 18 | 29 | 1016 | multi-organism reproductive process |
| GO:0001754 | 0.00909 | 5.27965 | 1 | 4 | 46 | eye photoreceptor cell differentiation |
| GO:0002067 | 0.00909 | 5.27965 | 1 | 4 | 46 | glandular epithelial cell differentiation |
| GO:1900015 | 0.00909 | 5.27965 | 1 | 4 | 46 | regulation of cytokine production involved in inflammatory response |
| GO:0072330 | 0.00915 | 2.20974 | 6 | 13 | 343 | monocarboxylic acid biosynthetic process |
| GO:0060840 | 0.00916 | 3.54995 | 2 | 6 | 100 | artery development |
| GO:0046394 | 0.00936 | 2.01822 | 8 | 16 | 462 | carboxylic acid biosynthetic process |
| GO:0045596 | 0.00939 | 1.77856 | 14 | 23 | 755 | negative regulation of cell differentiation |
| GO:0048729 | 0.00949 | 1.82846 | 12 | 21 | 670 | tissue morphogenesis |
| GO:0002683 | 0.00954 | 2.01359 | 8 | 16 | 463 | negative regulation of immune system process |
| GO:0016053 | 0.00954 | 2.01359 | 8 | 16 | 463 | organic acid biosynthetic process |
| GO:0032649 | 0.00960 | 3.51239 | 2 | 6 | 101 | regulation of interferon-gamma production |
| GO:0046632 | 0.00960 | 3.51239 | 2 | 6 | 101 | alpha-beta T cell differentiation |
| GO:0048661 | 0.00960 | 3.51239 | 2 | 6 | 101 | positive regulation of smooth muscle cell proliferation |
| GO:0055007 | 0.00968 | 3.11870 | 2 | 7 | 132 | cardiac muscle cell differentiation |
| GO:0002376 | 0.00972 | 1.38858 | 57 | 74 | 3193 | immune system process |
| GO:0002053 | 0.00975 | 7.54491 | 0 | 3 | 25 | positive regulation of mesenchymal cell proliferation |
| GO:0002068 | 0.00975 | 7.54491 | 0 | 3 | 25 | glandular epithelial cell development |
| GO:0030813 | 0.00975 | 7.54491 | 0 | 3 | 25 | positive regulation of nucleotide catabolic process |
| GO:0050927 | 0.00975 | 7.54491 | 0 | 3 | 25 | positive regulation of positive chemotaxis |
| GO:0051197 | 0.00975 | 7.54491 | 0 | 3 | 25 | positive regulation of coenzyme metabolic process |
| GO:0060561 | 0.00975 | 7.54491 | 0 | 3 | 25 | apoptotic process involved in morphogenesis |
| GO:0072273 | 0.00975 | 7.54491 | 0 | 3 | 25 | metanephric nephron morphogenesis |
| GO:0030261 | 0.00980 | 5.15659 | 1 | 4 | 47 | chromosome condensation |
| GO:0043370 | 0.00980 | 5.15659 | 1 | 4 | 47 | regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:0060351 | 0.00980 | 5.15659 | 1 | 4 | 47 | cartilage development involved in endochondral bone morphogenesis |
| GO:0070849 | 0.00980 | 5.15659 | 1 | 4 | 47 | response to epidermal growth factor |
| GO:0120163 | 0.00980 | 5.15659 | 1 | 4 | 47 | negative regulation of cold-induced thermogenesis |
| GO:0016052 | 0.00980 | 2.64476 | 4 | 9 | 199 | carbohydrate catabolic process |
| GO:0035966 | 0.00980 | 2.64476 | 4 | 9 | 199 | response to topologically incorrect protein |
| GO:0009755 | 0.00999 | 2.48436 | 4 | 10 | 235 | hormone-mediated signaling pathway |
| GO:0090288 | 0.01017 | 2.82333 | 3 | 8 | 166 | negative regulation of cellular response to growth factor stimulus |
| GO:0070997 | 0.01024 | 2.17616 | 6 | 13 | 348 | neuron death |
| GO:0001775 | 0.01029 | 1.55061 | 26 | 38 | 1440 | cell activation |
| GO:0061448 | 0.01041 | 2.34933 | 5 | 11 | 273 | connective tissue development |
| GO:0003006 | 0.01042 | 1.81109 | 12 | 21 | 676 | developmental process involved in reproduction |
| GO:0043367 | 0.01047 | 4.02339 | 1 | 5 | 74 | CD4-positive, alpha-beta T cell differentiation |
| GO:0044264 | 0.01051 | 3.43959 | 2 | 6 | 103 | cellular polysaccharide metabolic process |
| GO:0042059 | 0.01055 | 5.03912 | 1 | 4 | 48 | negative regulation of epidermal growth factor receptor signaling pathway |
| GO:0007050 | 0.01057 | 2.46220 | 4 | 10 | 237 | cell cycle arrest |
| GO:0003266 | 0.01057 | 15.77367 | 0 | 2 | 9 | regulation of secondary heart field cardioblast proliferation |
| GO:0010533 | 0.01057 | 15.77367 | 0 | 2 | 9 | regulation of activation of Janus kinase activity |
| GO:1905709 | 0.01057 | 15.77367 | 0 | 2 | 9 | negative regulation of membrane permeability |
| GO:2000018 | 0.01057 | 15.77367 | 0 | 2 | 9 | regulation of male gonad development |
| GO:0009746 | 0.01074 | 2.60322 | 4 | 9 | 202 | response to hexose |
| GO:0007498 | 0.01087 | 3.04511 | 2 | 7 | 135 | mesoderm development |
| GO:0050926 | 0.01088 | 7.21647 | 0 | 3 | 26 | regulation of positive chemotaxis |
| GO:0060669 | 0.01088 | 7.21647 | 0 | 3 | 26 | embryonic placenta morphogenesis |
| GO:0060706 | 0.01088 | 7.21647 | 0 | 3 | 26 | cell differentiation involved in embryonic placenta development |
| GO:0060914 | 0.01088 | 7.21647 | 0 | 3 | 26 | heart formation |
| GO:0072539 | 0.01088 | 7.21647 | 0 | 3 | 26 | T-helper 17 cell differentiation |
| GO:0097066 | 0.01088 | 7.21647 | 0 | 3 | 26 | response to thyroid hormone |
| GO:0003002 | 0.01094 | 2.15648 | 6 | 13 | 351 | regionalization |
| GO:0051260 | 0.01094 | 2.15648 | 6 | 13 | 351 | protein homooligomerization |
| GO:0043270 | 0.01095 | 2.33127 | 5 | 11 | 275 | positive regulation of ion transport |
| GO:1901214 | 0.01105 | 2.23293 | 6 | 12 | 313 | regulation of neuron death |
| GO:0003281 | 0.01106 | 3.96570 | 1 | 5 | 75 | ventricular septum development |
| GO:0048705 | 0.01116 | 2.44043 | 4 | 10 | 239 | skeletal system morphogenesis |
| GO:0002534 | 0.01132 | 4.92687 | 1 | 4 | 49 | cytokine production involved in inflammatory response |
| GO:0055082 | 0.01139 | 1.72405 | 15 | 24 | 812 | cellular chemical homeostasis |
| GO:0034764 | 0.01140 | 2.57624 | 4 | 9 | 204 | positive regulation of transmembrane transport |
| GO:0043436 | 0.01147 | 1.59833 | 21 | 32 | 1172 | oxoacid metabolic process |
| GO:0055017 | 0.01149 | 3.36973 | 2 | 6 | 105 | cardiac muscle tissue growth |
| GO:0042310 | 0.01167 | 3.90963 | 1 | 5 | 76 | vasoconstriction |
| GO:0048844 | 0.01167 | 3.90963 | 1 | 5 | 76 | artery morphogenesis |
| GO:0060411 | 0.01167 | 3.90963 | 1 | 5 | 76 | cardiac septum morphogenesis |
| GO:0072088 | 0.01167 | 3.90963 | 1 | 5 | 76 | nephron epithelium morphogenesis |
| GO:0046425 | 0.01173 | 2.99793 | 2 | 7 | 137 | regulation of JAK-STAT cascade |
| GO:0071222 | 0.01175 | 2.56295 | 4 | 9 | 205 | cellular response to lipopolysaccharide |
| GO:0003300 | 0.01200 | 3.33585 | 2 | 6 | 106 | cardiac muscle hypertrophy |
| GO:0035883 | 0.01208 | 6.91541 | 0 | 3 | 27 | enteroendocrine cell differentiation |
| GO:0046885 | 0.01208 | 6.91541 | 0 | 3 | 27 | regulation of hormone biosynthetic process |
| GO:0060259 | 0.01208 | 6.91541 | 0 | 3 | 27 | regulation of feeding behavior |
| GO:0072207 | 0.01208 | 6.91541 | 0 | 3 | 27 | metanephric epithelium development |
| GO:0080134 | 0.01212 | 1.50144 | 29 | 42 | 1645 | regulation of response to stress |
| GO:0009948 | 0.01214 | 4.81950 | 1 | 4 | 50 | anterior/posterior axis specification |
| GO:0010171 | 0.01214 | 4.81950 | 1 | 4 | 50 | body morphogenesis |
| GO:0009135 | 0.01217 | 2.97488 | 2 | 7 | 138 | purine nucleoside diphosphate metabolic process |
| GO:0009179 | 0.01217 | 2.97488 | 2 | 7 | 138 | purine ribonucleoside diphosphate metabolic process |
| GO:0046631 | 0.01217 | 2.97488 | 2 | 7 | 138 | alpha-beta T cell activation |
| GO:0016575 | 0.01230 | 3.85512 | 1 | 5 | 77 | histone deacetylation |
| GO:0034284 | 0.01245 | 2.53678 | 4 | 9 | 207 | response to monosaccharide |
| GO:0030330 | 0.01253 | 3.30264 | 2 | 6 | 107 | DNA damage response, signal transduction by p53 class mediator |
| GO:0050789 | 0.01257 | 1.31589 | 216 | 236 | 12093 | regulation of biological process |
| GO:0000271 | 0.01296 | 3.80210 | 1 | 5 | 78 | polysaccharide biosynthetic process |
| GO:0031016 | 0.01296 | 3.80210 | 1 | 5 | 78 | pancreas development |
| GO:0072028 | 0.01296 | 3.80210 | 1 | 5 | 78 | nephron morphogenesis |
| GO:1903313 | 0.01296 | 3.80210 | 1 | 5 | 78 | positive regulation of mRNA metabolic process |
| GO:0090102 | 0.01299 | 4.71670 | 1 | 4 | 51 | cochlea development |
| GO:0007028 | 0.01306 | 13.80120 | 0 | 2 | 10 | cytoplasm organization |
| GO:0032000 | 0.01306 | 13.80120 | 0 | 2 | 10 | positive regulation of fatty acid beta-oxidation |
| GO:0046322 | 0.01306 | 13.80120 | 0 | 2 | 10 | negative regulation of fatty acid oxidation |
| GO:0072124 | 0.01306 | 13.80120 | 0 | 2 | 10 | regulation of glomerular mesangial cell proliferation |
| GO:0090336 | 0.01306 | 13.80120 | 0 | 2 | 10 | positive regulation of brown fat cell differentiation |
| GO:1903897 | 0.01306 | 13.80120 | 0 | 2 | 10 | regulation of PERK-mediated unfolded protein response |
| GO:0009185 | 0.01309 | 2.92982 | 3 | 7 | 140 | ribonucleoside diphosphate metabolic process |
| GO:0003180 | 0.01335 | 6.63843 | 1 | 3 | 28 | aortic valve morphogenesis |
| GO:0006972 | 0.01335 | 6.63843 | 1 | 3 | 28 | hyperosmotic response |
| GO:0036296 | 0.01335 | 6.63843 | 1 | 3 | 28 | response to increased oxygen levels |
| GO:0015711 | 0.01357 | 1.92944 | 9 | 16 | 482 | organic anion transport |
| GO:0001570 | 0.01364 | 3.75051 | 1 | 5 | 79 | vasculogenesis |
| GO:2000677 | 0.01388 | 4.61818 | 1 | 4 | 52 | regulation of transcription regulatory region DNA binding |
| GO:0034976 | 0.01399 | 2.24494 | 5 | 11 | 285 | response to endoplasmic reticulum stress |
| GO:0038127 | 0.01406 | 2.88610 | 3 | 7 | 142 | ERBB signaling pathway |
| GO:0044270 | 0.01408 | 1.75544 | 12 | 21 | 696 | cellular nitrogen compound catabolic process |
| GO:0007049 | 0.01418 | 1.46012 | 33 | 46 | 1854 | cell cycle |
| GO:0045321 | 0.01423 | 1.54913 | 23 | 34 | 1284 | leukocyte activation |
| GO:0042219 | 0.01470 | 6.38276 | 1 | 3 | 29 | cellular modified amino acid catabolic process |
| GO:0072538 | 0.01470 | 6.38276 | 1 | 3 | 29 | T-helper 17 type immune response |
| GO:0009617 | 0.01470 | 1.74738 | 13 | 21 | 699 | response to bacterium |
| GO:0043269 | 0.01470 | 1.74738 | 13 | 21 | 699 | regulation of ion transport |
| GO:0050732 | 0.01481 | 4.52369 | 1 | 4 | 53 | negative regulation of peptidyl-tyrosine phosphorylation |
| GO:1901185 | 0.01481 | 4.52369 | 1 | 4 | 53 | negative regulation of ERBB signaling pathway |
| GO:0098656 | 0.01501 | 2.22026 | 5 | 11 | 288 | anion transmembrane transport |
| GO:0030512 | 0.01507 | 3.65142 | 1 | 5 | 81 | negative regulation of transforming growth factor beta receptor signaling pathway |
| GO:0030811 | 0.01507 | 3.65142 | 1 | 5 | 81 | regulation of nucleotide catabolic process |
| GO:0048708 | 0.01507 | 3.65142 | 1 | 5 | 81 | astrocyte differentiation |
| GO:0051707 | 0.01512 | 1.61185 | 18 | 28 | 1013 | response to other organism |
| GO:0071103 | 0.01515 | 2.13203 | 6 | 12 | 327 | DNA conformation change |
| GO:0015893 | 0.01518 | 2.44922 | 4 | 9 | 214 | drug transport |
| GO:0080135 | 0.01541 | 1.71529 | 13 | 22 | 746 | regulation of cellular response to stress |
| GO:0014902 | 0.01541 | 3.14600 | 2 | 6 | 112 | myotube differentiation |
| GO:0050868 | 0.01541 | 3.14600 | 2 | 6 | 112 | negative regulation of T cell activation |
| GO:0060419 | 0.01541 | 3.14600 | 2 | 6 | 112 | heart growth |
| GO:0009314 | 0.01542 | 1.94419 | 8 | 15 | 448 | response to radiation |
| GO:0043207 | 0.01548 | 1.60840 | 18 | 28 | 1015 | response to external biotic stimulus |
| GO:0071901 | 0.01562 | 2.82290 | 3 | 7 | 145 | negative regulation of protein serine/threonine kinase activity |
| GO:0000185 | 0.01577 | 12.26707 | 0 | 2 | 11 | activation of MAPKKK activity |
| GO:0009629 | 0.01577 | 12.26707 | 0 | 2 | 11 | response to gravity |
| GO:0019852 | 0.01577 | 12.26707 | 0 | 2 | 11 | L-ascorbic acid metabolic process |
| GO:0040015 | 0.01577 | 12.26707 | 0 | 2 | 11 | negative regulation of multicellular organism growth |
| GO:0043117 | 0.01577 | 12.26707 | 0 | 2 | 11 | positive regulation of vascular permeability |
| GO:0046886 | 0.01577 | 12.26707 | 0 | 2 | 11 | positive regulation of hormone biosynthetic process |
| GO:0060433 | 0.01577 | 12.26707 | 0 | 2 | 11 | bronchus development |
| GO:0060992 | 0.01577 | 12.26707 | 0 | 2 | 11 | response to fungicide |
| GO:0072110 | 0.01577 | 12.26707 | 0 | 2 | 11 | glomerular mesangial cell proliferation |
| GO:0072173 | 0.01577 | 12.26707 | 0 | 2 | 11 | metanephric tubule morphogenesis |
| GO:0090193 | 0.01577 | 12.26707 | 0 | 2 | 11 | positive regulation of glomerulus development |
| GO:1900102 | 0.01577 | 12.26707 | 0 | 2 | 11 | negative regulation of endoplasmic reticulum unfolded protein response |
| GO:1905941 | 0.01577 | 12.26707 | 0 | 2 | 11 | positive regulation of gonad development |
| GO:1990440 | 0.01577 | 12.26707 | 0 | 2 | 11 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress |
| GO:0032609 | 0.01604 | 3.11642 | 2 | 6 | 113 | interferon-gamma production |
| GO:0038111 | 0.01612 | 6.14602 | 1 | 3 | 30 | interleukin-7-mediated signaling pathway |
| GO:0061157 | 0.01612 | 6.14602 | 1 | 3 | 30 | mRNA destabilization |
| GO:0071549 | 0.01612 | 6.14602 | 1 | 3 | 30 | cellular response to dexamethasone stimulus |
| GO:1904892 | 0.01616 | 2.80243 | 3 | 7 | 146 | regulation of STAT cascade |
| GO:2001251 | 0.01616 | 2.80243 | 3 | 7 | 146 | negative regulation of chromosome organization |
| GO:0022408 | 0.01643 | 2.57640 | 3 | 8 | 181 | negative regulation of cell-cell adhesion |
| GO:0072503 | 0.01645 | 1.88379 | 9 | 16 | 493 | cellular divalent inorganic cation homeostasis |
| GO:0009410 | 0.01646 | 2.18817 | 5 | 11 | 292 | response to xenobiotic stimulus |
| GO:0090287 | 0.01646 | 2.18817 | 5 | 11 | 292 | regulation of cellular response to growth factor stimulus |
| GO:0045913 | 0.01659 | 3.55740 | 1 | 5 | 83 | positive regulation of carbohydrate metabolic process |
| GO:1903845 | 0.01659 | 3.55740 | 1 | 5 | 83 | negative regulation of cellular response to transforming growth factor beta stimulus |
| GO:0005976 | 0.01668 | 3.08740 | 2 | 6 | 114 | polysaccharide metabolic process |
| GO:0030282 | 0.01668 | 3.08740 | 2 | 6 | 114 | bone mineralization |
| GO:0034968 | 0.01668 | 3.08740 | 2 | 6 | 114 | histone lysine methylation |
| GO:0045446 | 0.01668 | 3.08740 | 2 | 6 | 114 | endothelial cell differentiation |
| GO:0060349 | 0.01668 | 3.08740 | 2 | 6 | 114 | bone morphogenesis |
| GO:0002262 | 0.01672 | 2.78226 | 3 | 7 | 147 | myeloid cell homeostasis |
| GO:0019359 | 0.01672 | 2.78226 | 3 | 7 | 147 | nicotinamide nucleotide biosynthetic process |
| GO:0019363 | 0.01672 | 2.78226 | 3 | 7 | 147 | pyridine nucleotide biosynthetic process |
| GO:0071236 | 0.01672 | 2.78226 | 3 | 7 | 147 | cellular response to antibiotic |
| GO:0003008 | 0.01676 | 1.41027 | 40 | 53 | 2216 | system process |
| GO:0042304 | 0.01678 | 4.34581 | 1 | 4 | 55 | regulation of fatty acid biosynthetic process |
| GO:0022409 | 0.01688 | 2.27904 | 5 | 10 | 255 | positive regulation of cell-cell adhesion |
| GO:0009166 | 0.01692 | 2.56146 | 3 | 8 | 182 | nucleotide catabolic process |
| GO:0010001 | 0.01693 | 2.40181 | 4 | 9 | 218 | glial cell differentiation |
| GO:1903039 | 0.01693 | 2.40181 | 4 | 9 | 218 | positive regulation of leukocyte cell-cell adhesion |
| GO:0002009 | 0.01701 | 1.83737 | 10 | 17 | 537 | morphogenesis of an epithelium |
| GO:0015849 | 0.01723 | 2.09148 | 6 | 12 | 333 | organic acid transport |
| GO:0046942 | 0.01723 | 2.09148 | 6 | 12 | 333 | carboxylic acid transport |
| GO:0050730 | 0.01730 | 2.26965 | 5 | 10 | 256 | regulation of peptidyl-tyrosine phosphorylation |
| GO:0006096 | 0.01735 | 3.05891 | 2 | 6 | 115 | glycolytic process |
| GO:0009952 | 0.01739 | 2.39024 | 4 | 9 | 219 | anterior/posterior pattern specification |
| GO:0043583 | 0.01739 | 2.39024 | 4 | 9 | 219 | ear development |
| GO:0046889 | 0.01739 | 3.51218 | 2 | 5 | 84 | positive regulation of lipid biosynthetic process |
| GO:0097756 | 0.01739 | 3.51218 | 2 | 5 | 84 | negative regulation of blood vessel diameter |
| GO:0009127 | 0.01743 | 2.54668 | 3 | 8 | 183 | purine nucleoside monophosphate biosynthetic process |
| GO:0009168 | 0.01743 | 2.54668 | 3 | 8 | 183 | purine ribonucleoside monophosphate biosynthetic process |
| GO:0007202 | 0.01761 | 5.92620 | 1 | 3 | 31 | activation of phospholipase C activity |
| GO:0010719 | 0.01761 | 5.92620 | 1 | 3 | 31 | negative regulation of epithelial to mesenchymal transition |
| GO:0010762 | 0.01761 | 5.92620 | 1 | 3 | 31 | regulation of fibroblast migration |
| GO:0035767 | 0.01761 | 5.92620 | 1 | 3 | 31 | endothelial cell chemotaxis |
| GO:0043457 | 0.01761 | 5.92620 | 1 | 3 | 31 | regulation of cellular respiration |
| GO:0048710 | 0.01761 | 5.92620 | 1 | 3 | 31 | regulation of astrocyte differentiation |
| GO:0006977 | 0.01782 | 4.26200 | 1 | 4 | 56 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest |
| GO:0051568 | 0.01782 | 4.26200 | 1 | 4 | 56 | histone H3-K4 methylation |
| GO:0000415 | 0.01789 | Inf | 0 | 1 | 1 | negative regulation of histone H3-K36 methylation |
| GO:0002510 | 0.01789 | Inf | 0 | 1 | 1 | central B cell tolerance induction |
| GO:0002646 | 0.01789 | Inf | 0 | 1 | 1 | regulation of central tolerance induction |
| GO:0002648 | 0.01789 | Inf | 0 | 1 | 1 | positive regulation of central tolerance induction |
| GO:0002895 | 0.01789 | Inf | 0 | 1 | 1 | regulation of central B cell tolerance induction |
| GO:0002897 | 0.01789 | Inf | 0 | 1 | 1 | positive regulation of central B cell tolerance induction |
| GO:0003421 | 0.01789 | Inf | 0 | 1 | 1 | growth plate cartilage axis specification |
| GO:0009444 | 0.01789 | Inf | 0 | 1 | 1 | pyruvate oxidation |
| GO:0010335 | 0.01789 | Inf | 0 | 1 | 1 | response to non-ionic osmotic stress |
| GO:0014828 | 0.01789 | Inf | 0 | 1 | 1 | distal stomach smooth muscle contraction |
| GO:0018272 | 0.01789 | Inf | 0 | 1 | 1 | protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine |
| GO:0018917 | 0.01789 | Inf | 0 | 1 | 1 | fluorene metabolic process |
| GO:0019244 | 0.01789 | Inf | 0 | 1 | 1 | lactate biosynthetic process from pyruvate |
| GO:0032498 | 0.01789 | Inf | 0 | 1 | 1 | detection of muramyl dipeptide |
| GO:0033575 | 0.01789 | Inf | 0 | 1 | 1 | protein glycosylation at cell surface |
| GO:0033580 | 0.01789 | Inf | 0 | 1 | 1 | protein galactosylation at cell surface |
| GO:0034443 | 0.01789 | Inf | 0 | 1 | 1 | negative regulation of lipoprotein oxidation |
| GO:0035622 | 0.01789 | Inf | 0 | 1 | 1 | intrahepatic bile duct development |
| GO:0036497 | 0.01789 | Inf | 0 | 1 | 1 | eIF2alpha dephosphorylation in response to endoplasmic reticulum stress |
| GO:0038097 | 0.01789 | Inf | 0 | 1 | 1 | positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway |
| GO:0038133 | 0.01789 | Inf | 0 | 1 | 1 | ERBB2-ERBB3 signaling pathway |
| GO:0042125 | 0.01789 | Inf | 0 | 1 | 1 | protein galactosylation |
| GO:0042413 | 0.01789 | Inf | 0 | 1 | 1 | carnitine catabolic process |
| GO:0042843 | 0.01789 | Inf | 0 | 1 | 1 | D-xylose catabolic process |
| GO:0043390 | 0.01789 | Inf | 0 | 1 | 1 | aflatoxin B1 metabolic process |
| GO:0044524 | 0.01789 | Inf | 0 | 1 | 1 | protein sulfhydration |
| GO:0044722 | 0.01789 | Inf | 0 | 1 | 1 | renal phosphate excretion |
| GO:0045366 | 0.01789 | Inf | 0 | 1 | 1 | regulation of interleukin-13 biosynthetic process |
| GO:0045368 | 0.01789 | Inf | 0 | 1 | 1 | positive regulation of interleukin-13 biosynthetic process |
| GO:0045977 | 0.01789 | Inf | 0 | 1 | 1 | positive regulation of mitotic cell cycle, embryonic |
| GO:0046293 | 0.01789 | Inf | 0 | 1 | 1 | formaldehyde biosynthetic process |
| GO:0060010 | 0.01789 | Inf | 0 | 1 | 1 | Sertoli cell fate commitment |
| GO:0060517 | 0.01789 | Inf | 0 | 1 | 1 | epithelial cell proliferation involved in prostatic bud elongation |
| GO:0060588 | 0.01789 | Inf | 0 | 1 | 1 | negative regulation of lipoprotein lipid oxidation |
| GO:0060784 | 0.01789 | Inf | 0 | 1 | 1 | regulation of cell proliferation involved in tissue homeostasis |
| GO:0061105 | 0.01789 | Inf | 0 | 1 | 1 | regulation of stomach neuroendocrine cell differentiation |
| GO:0061106 | 0.01789 | Inf | 0 | 1 | 1 | negative regulation of stomach neuroendocrine cell differentiation |
| GO:0061143 | 0.01789 | Inf | 0 | 1 | 1 | alveolar primary septum development |
| GO:0061586 | 0.01789 | Inf | 0 | 1 | 1 | positive regulation of transcription by transcription factor localization |
| GO:0061868 | 0.01789 | Inf | 0 | 1 | 1 | hepatic stellate cell migration |
| GO:0061869 | 0.01789 | Inf | 0 | 1 | 1 | regulation of hepatic stellate cell migration |
| GO:0061870 | 0.01789 | Inf | 0 | 1 | 1 | positive regulation of hepatic stellate cell migration |
| GO:0070060 | 0.01789 | Inf | 0 | 1 | 1 | 'de novo' actin filament nucleation |
| GO:0070407 | 0.01789 | Inf | 0 | 1 | 1 | oxidation-dependent protein catabolic process |
| GO:0071387 | 0.01789 | Inf | 0 | 1 | 1 | cellular response to cortisol stimulus |
| GO:0071471 | 0.01789 | Inf | 0 | 1 | 1 | cellular response to non-ionic osmotic stress |
| GO:0071938 | 0.01789 | Inf | 0 | 1 | 1 | vitamin A transport |
| GO:0071939 | 0.01789 | Inf | 0 | 1 | 1 | vitamin A import |
| GO:0072016 | 0.01789 | Inf | 0 | 1 | 1 | glomerular parietal epithelial cell development |
| GO:0072303 | 0.01789 | Inf | 0 | 1 | 1 | positive regulation of glomerular metanephric mesangial cell proliferation |
| GO:0086050 | 0.01789 | Inf | 0 | 1 | 1 | membrane repolarization during bundle of His cell action potential |
| GO:0086052 | 0.01789 | Inf | 0 | 1 | 1 | membrane repolarization during SA node cell action potential |
| GO:0097326 | 0.01789 | Inf | 0 | 1 | 1 | melanocyte adhesion |
| GO:0099156 | 0.01789 | Inf | 0 | 1 | 1 | cell-cell signaling via exosome |
| GO:0120064 | 0.01789 | Inf | 0 | 1 | 1 | stomach pylorus smooth muscle contraction |
| GO:0120065 | 0.01789 | Inf | 0 | 1 | 1 | pyloric antrum smooth muscle contraction |
| GO:0120071 | 0.01789 | Inf | 0 | 1 | 1 | regulation of pyloric antrum smooth muscle contraction |
| GO:0120072 | 0.01789 | Inf | 0 | 1 | 1 | positive regulation of pyloric antrum smooth muscle contraction |
| GO:1900036 | 0.01789 | Inf | 0 | 1 | 1 | positive regulation of cellular response to heat |
| GO:1900143 | 0.01789 | Inf | 0 | 1 | 1 | positive regulation of oligodendrocyte apoptotic process |
| GO:1901248 | 0.01789 | Inf | 0 | 1 | 1 | positive regulation of lung ciliated cell differentiation |
| GO:1901676 | 0.01789 | Inf | 0 | 1 | 1 | positive regulation of histone H3-K27 acetylation |
| GO:1901834 | 0.01789 | Inf | 0 | 1 | 1 | regulation of deadenylation-independent decapping of nuclear-transcribed mRNA |
| GO:1901835 | 0.01789 | Inf | 0 | 1 | 1 | positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA |
| GO:1902010 | 0.01789 | Inf | 0 | 1 | 1 | negative regulation of translation in response to endoplasmic reticulum stress |
| GO:1903402 | 0.01789 | Inf | 0 | 1 | 1 | regulation of renal phosphate excretion |
| GO:1903403 | 0.01789 | Inf | 0 | 1 | 1 | negative regulation of renal phosphate excretion |
| GO:1903570 | 0.01789 | Inf | 0 | 1 | 1 | regulation of protein kinase D signaling |
| GO:1903572 | 0.01789 | Inf | 0 | 1 | 1 | positive regulation of protein kinase D signaling |
| GO:1903916 | 0.01789 | Inf | 0 | 1 | 1 | regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation |
| GO:1903917 | 0.01789 | Inf | 0 | 1 | 1 | positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation |
| GO:1904233 | 0.01789 | Inf | 0 | 1 | 1 | negative regulation of aconitate hydratase activity |
| GO:1904246 | 0.01789 | Inf | 0 | 1 | 1 | negative regulation of polynucleotide adenylyltransferase activity |
| GO:1904341 | 0.01789 | Inf | 0 | 1 | 1 | regulation of colon smooth muscle contraction |
| GO:1904343 | 0.01789 | Inf | 0 | 1 | 1 | positive regulation of colon smooth muscle contraction |
| GO:1904998 | 0.01789 | Inf | 0 | 1 | 1 | negative regulation of leukocyte adhesion to arterial endothelial cell |
| GO:1905062 | 0.01789 | Inf | 0 | 1 | 1 | positive regulation of cardioblast proliferation |
| GO:1905933 | 0.01789 | Inf | 0 | 1 | 1 | regulation of cell fate determination |
| GO:1905934 | 0.01789 | Inf | 0 | 1 | 1 | negative regulation of cell fate determination |
| GO:1990079 | 0.01789 | Inf | 0 | 1 | 1 | cartilage homeostasis |
| GO:1990765 | 0.01789 | Inf | 0 | 1 | 1 | colon smooth muscle contraction |
| GO:2000226 | 0.01789 | Inf | 0 | 1 | 1 | regulation of pancreatic A cell differentiation |
| GO:2000227 | 0.01789 | Inf | 0 | 1 | 1 | negative regulation of pancreatic A cell differentiation |
| GO:2000422 | 0.01789 | Inf | 0 | 1 | 1 | regulation of eosinophil chemotaxis |
| GO:2000424 | 0.01789 | Inf | 0 | 1 | 1 | positive regulation of eosinophil chemotaxis |
| GO:2000487 | 0.01789 | Inf | 0 | 1 | 1 | positive regulation of glutamine transport |
| GO:0006757 | 0.01803 | 3.03093 | 2 | 6 | 116 | ATP generation from ADP |
| GO:0008015 | 0.01815 | 1.82293 | 10 | 17 | 541 | blood circulation |
| GO:0006874 | 0.01843 | 1.89924 | 8 | 15 | 458 | cellular calcium ion homeostasis |
| GO:0048754 | 0.01847 | 2.72344 | 3 | 7 | 150 | branching morphogenesis of an epithelial tube |
| GO:0071774 | 0.01847 | 2.72344 | 3 | 7 | 150 | response to fibroblast growth factor |
| GO:0072525 | 0.01847 | 2.72344 | 3 | 7 | 150 | pyridine-containing compound biosynthetic process |
| GO:1902275 | 0.01848 | 2.51763 | 3 | 8 | 185 | regulation of chromatin organization |
| GO:0002371 | 0.01871 | 11.03976 | 0 | 2 | 12 | dendritic cell cytokine production |
| GO:0006983 | 0.01871 | 11.03976 | 0 | 2 | 12 | ER overload response |
| GO:0030950 | 0.01871 | 11.03976 | 0 | 2 | 12 | establishment or maintenance of actin cytoskeleton polarity |
| GO:0031392 | 0.01871 | 11.03976 | 0 | 2 | 12 | regulation of prostaglandin biosynthetic process |
| GO:0050910 | 0.01871 | 11.03976 | 0 | 2 | 12 | detection of mechanical stimulus involved in sensory perception of sound |
| GO:0060707 | 0.01871 | 11.03976 | 0 | 2 | 12 | trophoblast giant cell differentiation |
| GO:0071257 | 0.01871 | 11.03976 | 0 | 2 | 12 | cellular response to electrical stimulus |
| GO:0090209 | 0.01871 | 11.03976 | 0 | 2 | 12 | negative regulation of triglyceride metabolic process |
| GO:0097201 | 0.01871 | 11.03976 | 0 | 2 | 12 | negative regulation of transcription from RNA polymerase II promoter in response to stress |
| GO:1902337 | 0.01871 | 11.03976 | 0 | 2 | 12 | regulation of apoptotic process involved in morphogenesis |
| GO:0002761 | 0.01873 | 3.00346 | 2 | 6 | 117 | regulation of myeloid leukocyte differentiation |
| GO:0010508 | 0.01873 | 3.00346 | 2 | 6 | 117 | positive regulation of autophagy |
| GO:0019320 | 0.01890 | 4.18136 | 1 | 4 | 57 | hexose catabolic process |
| GO:0072431 | 0.01890 | 4.18136 | 1 | 4 | 57 | signal transduction involved in mitotic G1 DNA damage checkpoint |
| GO:1902400 | 0.01890 | 4.18136 | 1 | 4 | 57 | intracellular signal transduction involved in G1 DNA damage checkpoint |
| GO:1903428 | 0.01890 | 4.18136 | 1 | 4 | 57 | positive regulation of reactive oxygen species biosynthetic process |
| GO:0042446 | 0.01907 | 3.42508 | 2 | 5 | 86 | hormone biosynthetic process |
| GO:0055085 | 0.01909 | 1.46516 | 29 | 40 | 1598 | transmembrane transport |
| GO:0048589 | 0.01918 | 1.72208 | 12 | 20 | 674 | developmental growth |
| GO:1904467 | 0.01918 | 5.72153 | 1 | 3 | 32 | regulation of tumor necrosis factor secretion |
| GO:0045137 | 0.01931 | 2.34505 | 4 | 9 | 223 | development of primary sexual characteristics |
| GO:0000187 | 0.01971 | 2.68558 | 3 | 7 | 152 | activation of MAPK activity |
| GO:0001678 | 0.01971 | 2.68558 | 3 | 7 | 152 | cellular glucose homeostasis |
| GO:0017001 | 0.02002 | 4.10370 | 1 | 4 | 58 | antibiotic catabolic process |
| GO:0042093 | 0.02002 | 4.10370 | 1 | 4 | 58 | T-helper cell differentiation |
| GO:1901292 | 0.02014 | 2.47526 | 3 | 8 | 188 | nucleoside phosphate catabolic process |
| GO:0007173 | 0.02018 | 2.94998 | 2 | 6 | 119 | epidermal growth factor receptor signaling pathway |
| GO:0042866 | 0.02018 | 2.94998 | 2 | 6 | 119 | pyruvate biosynthetic process |
| GO:0051193 | 0.02018 | 2.94998 | 2 | 6 | 119 | regulation of cofactor metabolic process |
| GO:0019362 | 0.02072 | 2.46144 | 3 | 8 | 189 | pyridine nucleotide metabolic process |
| GO:0046496 | 0.02072 | 2.46144 | 3 | 8 | 189 | nicotinamide nucleotide metabolic process |
| GO:0010464 | 0.02083 | 5.53051 | 1 | 3 | 33 | regulation of mesenchymal cell proliferation |
| GO:0051194 | 0.02083 | 5.53051 | 1 | 3 | 33 | positive regulation of cofactor metabolic process |
| GO:0051955 | 0.02083 | 5.53051 | 1 | 3 | 33 | regulation of amino acid transport |
| GO:0043470 | 0.02085 | 3.34218 | 2 | 5 | 88 | regulation of carbohydrate catabolic process |
| GO:1901888 | 0.02085 | 3.34218 | 2 | 5 | 88 | regulation of cell junction assembly |
| GO:0017015 | 0.02093 | 2.92394 | 2 | 6 | 120 | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0001101 | 0.02116 | 2.02717 | 6 | 12 | 343 | response to acid chemical |
| GO:0001885 | 0.02119 | 4.02887 | 1 | 4 | 59 | endothelial cell development |
| GO:0010656 | 0.02119 | 4.02887 | 1 | 4 | 59 | negative regulation of muscle cell apoptotic process |
| GO:0031102 | 0.02119 | 4.02887 | 1 | 4 | 59 | neuron projection regeneration |
| GO:0032890 | 0.02119 | 4.02887 | 1 | 4 | 59 | regulation of organic acid transport |
| GO:0072413 | 0.02119 | 4.02887 | 1 | 4 | 59 | signal transduction involved in mitotic cell cycle checkpoint |
| GO:1902402 | 0.02119 | 4.02887 | 1 | 4 | 59 | signal transduction involved in mitotic DNA damage checkpoint |
| GO:1902403 | 0.02119 | 4.02887 | 1 | 4 | 59 | signal transduction involved in mitotic DNA integrity checkpoint |
| GO:0003013 | 0.02124 | 1.78779 | 10 | 17 | 551 | circulatory system process |
| GO:0002682 | 0.02140 | 1.44585 | 30 | 41 | 1659 | regulation of immune system process |
| GO:0060326 | 0.02146 | 2.09716 | 5 | 11 | 304 | cell chemotaxis |
| GO:0060284 | 0.02180 | 1.58532 | 17 | 26 | 953 | regulation of cell development |
| GO:0001845 | 0.02185 | 10.03560 | 0 | 2 | 13 | phagolysosome assembly |
| GO:0003084 | 0.02185 | 10.03560 | 0 | 2 | 13 | positive regulation of systemic arterial blood pressure |
| GO:0014745 | 0.02185 | 10.03560 | 0 | 2 | 13 | negative regulation of muscle adaptation |
| GO:0031953 | 0.02185 | 10.03560 | 0 | 2 | 13 | negative regulation of protein autophosphorylation |
| GO:0042532 | 0.02185 | 10.03560 | 0 | 2 | 13 | negative regulation of tyrosine phosphorylation of STAT protein |
| GO:0042711 | 0.02185 | 10.03560 | 0 | 2 | 13 | maternal behavior |
| GO:0042908 | 0.02185 | 10.03560 | 0 | 2 | 13 | xenobiotic transport |
| GO:0048711 | 0.02185 | 10.03560 | 0 | 2 | 13 | positive regulation of astrocyte differentiation |
| GO:0050872 | 0.02185 | 10.03560 | 0 | 2 | 13 | white fat cell differentiation |
| GO:0060576 | 0.02185 | 10.03560 | 0 | 2 | 13 | intestinal epithelial cell development |
| GO:0060746 | 0.02185 | 10.03560 | 0 | 2 | 13 | parental behavior |
| GO:0061000 | 0.02185 | 10.03560 | 0 | 2 | 13 | negative regulation of dendritic spine development |
| GO:1901550 | 0.02185 | 10.03560 | 0 | 2 | 13 | regulation of endothelial cell development |
| GO:1902713 | 0.02185 | 10.03560 | 0 | 2 | 13 | regulation of interferon-gamma secretion |
| GO:1903025 | 0.02185 | 10.03560 | 0 | 2 | 13 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:1903140 | 0.02185 | 10.03560 | 0 | 2 | 13 | regulation of establishment of endothelial barrier |
| GO:1904251 | 0.02185 | 10.03560 | 0 | 2 | 13 | regulation of bile acid metabolic process |
| GO:0007259 | 0.02236 | 2.61291 | 3 | 7 | 156 | JAK-STAT cascade |
| GO:0002294 | 0.02239 | 3.95671 | 1 | 4 | 60 | CD4-positive, alpha-beta T cell differentiation involved in immune response |
| GO:0046324 | 0.02239 | 3.95671 | 1 | 4 | 60 | regulation of glucose import |
| GO:0043500 | 0.02250 | 2.87321 | 2 | 6 | 122 | muscle adaptation |
| GO:1903844 | 0.02250 | 2.87321 | 2 | 6 | 122 | regulation of cellular response to transforming growth factor beta stimulus |
| GO:0031128 | 0.02255 | 5.35182 | 1 | 3 | 34 | developmental induction |
| GO:0060795 | 0.02255 | 5.35182 | 1 | 3 | 34 | cell fate commitment involved in formation of primary germ layer |
| GO:0032651 | 0.02273 | 3.26319 | 2 | 5 | 90 | regulation of interleukin-1 beta production |
| GO:0072507 | 0.02287 | 1.80596 | 9 | 16 | 513 | divalent inorganic cation homeostasis |
| GO:0055074 | 0.02300 | 1.84376 | 8 | 15 | 471 | calcium ion homeostasis |
| GO:0009743 | 0.02305 | 2.26989 | 4 | 9 | 230 | response to carbohydrate |
| GO:0048699 | 0.02332 | 1.45570 | 27 | 38 | 1524 | generation of neurons |
| GO:0007249 | 0.02345 | 2.15418 | 5 | 10 | 269 | I-kappaB kinase/NF-kappaB signaling |
| GO:0002287 | 0.02363 | 3.88708 | 1 | 4 | 61 | alpha-beta T cell activation involved in immune response |
| GO:0002293 | 0.02363 | 3.88708 | 1 | 4 | 61 | alpha-beta T cell differentiation involved in immune response |
| GO:0045604 | 0.02363 | 3.88708 | 1 | 4 | 61 | regulation of epidermal cell differentiation |
| GO:2000514 | 0.02363 | 3.88708 | 1 | 4 | 61 | regulation of CD4-positive, alpha-beta T cell activation |
| GO:0009132 | 0.02377 | 2.57802 | 3 | 7 | 158 | nucleoside diphosphate metabolic process |
| GO:0007548 | 0.02398 | 2.14577 | 5 | 10 | 270 | sex differentiation |
| GO:0014066 | 0.02414 | 2.82420 | 2 | 6 | 124 | regulation of phosphatidylinositol 3-kinase signaling |
| GO:0015695 | 0.02434 | 5.18429 | 1 | 3 | 35 | organic cation transport |
| GO:0032689 | 0.02434 | 5.18429 | 1 | 3 | 35 | negative regulation of interferon-gamma production |
| GO:0042462 | 0.02434 | 5.18429 | 1 | 3 | 35 | eye photoreceptor cell development |
| GO:0045622 | 0.02434 | 5.18429 | 1 | 3 | 35 | regulation of T-helper cell differentiation |
| GO:0051954 | 0.02434 | 5.18429 | 1 | 3 | 35 | positive regulation of amine transport |
| GO:0070423 | 0.02434 | 5.18429 | 1 | 3 | 35 | nucleotide-binding oligomerization domain containing signaling pathway |
| GO:1905332 | 0.02434 | 5.18429 | 1 | 3 | 35 | positive regulation of morphogenesis of an epithelium |
| GO:1990774 | 0.02434 | 5.18429 | 1 | 3 | 35 | tumor necrosis factor secretion |
| GO:0072524 | 0.02442 | 2.38168 | 3 | 8 | 195 | pyridine-containing compound metabolic process |
| GO:0034655 | 0.02462 | 1.69800 | 12 | 19 | 648 | nucleobase-containing compound catabolic process |
| GO:0035710 | 0.02472 | 3.18782 | 2 | 5 | 92 | CD4-positive, alpha-beta T cell activation |
| GO:0001501 | 0.02473 | 1.78747 | 9 | 16 | 518 | skeletal system development |
| GO:0010830 | 0.02492 | 3.81985 | 1 | 4 | 62 | regulation of myotube differentiation |
| GO:0070059 | 0.02492 | 3.81985 | 1 | 4 | 62 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
| GO:2000134 | 0.02499 | 2.80032 | 2 | 6 | 125 | negative regulation of G1/S transition of mitotic cell cycle |
| GO:0003188 | 0.02520 | 9.19880 | 0 | 2 | 14 | heart valve formation |
| GO:0007175 | 0.02520 | 9.19880 | 0 | 2 | 14 | negative regulation of epidermal growth factor-activated receptor activity |
| GO:0033169 | 0.02520 | 9.19880 | 0 | 2 | 14 | histone H3-K9 demethylation |
| GO:0035358 | 0.02520 | 9.19880 | 0 | 2 | 14 | regulation of peroxisome proliferator activated receptor signaling pathway |
| GO:0043374 | 0.02520 | 9.19880 | 0 | 2 | 14 | CD8-positive, alpha-beta T cell differentiation |
| GO:0043558 | 0.02520 | 9.19880 | 0 | 2 | 14 | regulation of translational initiation in response to stress |
| GO:0045651 | 0.02520 | 9.19880 | 0 | 2 | 14 | positive regulation of macrophage differentiation |
| GO:0050930 | 0.02520 | 9.19880 | 0 | 2 | 14 | induction of positive chemotaxis |
| GO:0072216 | 0.02520 | 9.19880 | 0 | 2 | 14 | positive regulation of metanephros development |
| GO:1901722 | 0.02520 | 9.19880 | 0 | 2 | 14 | regulation of cell proliferation involved in kidney development |
| GO:1904748 | 0.02520 | 9.19880 | 0 | 2 | 14 | regulation of apoptotic process involved in development |
| GO:2001279 | 0.02520 | 9.19880 | 0 | 2 | 14 | regulation of unsaturated fatty acid biosynthetic process |
| GO:0006754 | 0.02524 | 2.54404 | 3 | 7 | 160 | ATP biosynthetic process |
| GO:0032680 | 0.02524 | 2.54404 | 3 | 7 | 160 | regulation of tumor necrosis factor production |
| GO:0046700 | 0.02556 | 1.66653 | 12 | 20 | 695 | heterocycle catabolic process |
| GO:0010959 | 0.02571 | 1.90853 | 7 | 13 | 394 | regulation of metal ion transport |
| GO:0009156 | 0.02575 | 2.35622 | 4 | 8 | 197 | ribonucleoside monophosphate biosynthetic process |
| GO:0009749 | 0.02575 | 2.35622 | 4 | 8 | 197 | response to glucose |
| GO:0006476 | 0.02575 | 3.15142 | 2 | 5 | 93 | protein deacetylation |
| GO:0033273 | 0.02575 | 3.15142 | 2 | 5 | 93 | response to vitamin |
| GO:0072080 | 0.02575 | 3.15142 | 2 | 5 | 93 | nephron tubule development |
| GO:0090101 | 0.02586 | 2.77683 | 2 | 6 | 126 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0051129 | 0.02601 | 1.64153 | 13 | 21 | 741 | negative regulation of cellular component organization |
| GO:0002755 | 0.02621 | 5.02692 | 1 | 3 | 36 | MyD88-dependent toll-like receptor signaling pathway |
| GO:0003417 | 0.02621 | 5.02692 | 1 | 3 | 36 | growth plate cartilage development |
| GO:0006007 | 0.02621 | 5.02692 | 1 | 3 | 36 | glucose catabolic process |
| GO:0035872 | 0.02621 | 5.02692 | 1 | 3 | 36 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway |
| GO:0046627 | 0.02621 | 5.02692 | 1 | 3 | 36 | negative regulation of insulin receptor signaling pathway |
| GO:0031571 | 0.02624 | 3.75490 | 1 | 4 | 63 | mitotic G1 DNA damage checkpoint |
| GO:0044819 | 0.02624 | 3.75490 | 1 | 4 | 63 | mitotic G1/S transition checkpoint |
| GO:0045815 | 0.02624 | 3.75490 | 1 | 4 | 63 | positive regulation of gene expression, epigenetic |
| GO:0046530 | 0.02624 | 3.75490 | 1 | 4 | 63 | photoreceptor cell differentiation |
| GO:0046637 | 0.02624 | 3.75490 | 1 | 4 | 63 | regulation of alpha-beta T cell differentiation |
| GO:0046686 | 0.02624 | 3.75490 | 1 | 4 | 63 | response to cadmium ion |
| GO:0051049 | 0.02637 | 1.40104 | 34 | 45 | 1879 | regulation of transport |
| GO:0031099 | 0.02644 | 2.34369 | 4 | 8 | 198 | regeneration |
| GO:0032872 | 0.02727 | 2.19935 | 4 | 9 | 237 | regulation of stress-activated MAPK cascade |
| GO:0034762 | 0.02740 | 1.73098 | 10 | 17 | 568 | regulation of transmembrane transport |
| GO:0032640 | 0.02756 | 2.49471 | 3 | 7 | 163 | tumor necrosis factor production |
| GO:1903555 | 0.02756 | 2.49471 | 3 | 7 | 163 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0044783 | 0.02761 | 3.69212 | 1 | 4 | 64 | G1 DNA damage checkpoint |
| GO:2000378 | 0.02761 | 3.69212 | 1 | 4 | 64 | negative regulation of reactive oxygen species metabolic process |
| GO:0055006 | 0.02791 | 3.08105 | 2 | 5 | 95 | cardiac cell development |
| GO:0061326 | 0.02791 | 3.08105 | 2 | 5 | 95 | renal tubule development |
| GO:0046578 | 0.02791 | 2.18963 | 4 | 9 | 238 | regulation of Ras protein signal transduction |
| GO:0000289 | 0.02816 | 4.87880 | 1 | 3 | 37 | nuclear-transcribed mRNA poly(A) tail shortening |
| GO:0031076 | 0.02816 | 4.87880 | 1 | 3 | 37 | embryonic camera-type eye development |
| GO:0071276 | 0.02816 | 4.87880 | 1 | 3 | 37 | cellular response to cadmium ion |
| GO:0098609 | 0.02852 | 1.58786 | 15 | 23 | 839 | cell-cell adhesion |
| GO:0018193 | 0.02857 | 1.47749 | 23 | 32 | 1259 | peptidyl-amino acid modification |
| GO:0051402 | 0.02857 | 2.17999 | 4 | 9 | 239 | neuron apoptotic process |
| GO:0070302 | 0.02857 | 2.17999 | 4 | 9 | 239 | regulation of stress-activated protein kinase signaling cascade |
| GO:0018022 | 0.02859 | 2.70866 | 2 | 6 | 129 | peptidyl-lysine methylation |
| GO:0007264 | 0.02862 | 1.72132 | 10 | 17 | 571 | small GTPase mediated signal transduction |
| GO:0006000 | 0.02873 | 8.49073 | 0 | 2 | 15 | fructose metabolic process |
| GO:0009109 | 0.02873 | 8.49073 | 0 | 2 | 15 | coenzyme catabolic process |
| GO:0015802 | 0.02873 | 8.49073 | 0 | 2 | 15 | basic amino acid transport |
| GO:0030238 | 0.02873 | 8.49073 | 0 | 2 | 15 | male sex determination |
| GO:0030852 | 0.02873 | 8.49073 | 0 | 2 | 15 | regulation of granulocyte differentiation |
| GO:0032736 | 0.02873 | 8.49073 | 0 | 2 | 15 | positive regulation of interleukin-13 production |
| GO:0034616 | 0.02873 | 8.49073 | 0 | 2 | 15 | response to laminar fluid shear stress |
| GO:0042921 | 0.02873 | 8.49073 | 0 | 2 | 15 | glucocorticoid receptor signaling pathway |
| GO:0043249 | 0.02873 | 8.49073 | 0 | 2 | 15 | erythrocyte maturation |
| GO:0051770 | 0.02873 | 8.49073 | 0 | 2 | 15 | positive regulation of nitric-oxide synthase biosynthetic process |
| GO:0071474 | 0.02873 | 8.49073 | 0 | 2 | 15 | cellular hyperosmotic response |
| GO:0090192 | 0.02873 | 8.49073 | 0 | 2 | 15 | regulation of glomerulus development |
| GO:1905065 | 0.02873 | 8.49073 | 0 | 2 | 15 | positive regulation of vascular smooth muscle cell differentiation |
| GO:2001185 | 0.02873 | 8.49073 | 0 | 2 | 15 | regulation of CD8-positive, alpha-beta T cell activation |
| GO:0060675 | 0.02902 | 3.63140 | 1 | 4 | 65 | ureteric bud morphogenesis |
| GO:0010660 | 0.02903 | 3.04703 | 2 | 5 | 96 | regulation of muscle cell apoptotic process |
| GO:0097327 | 0.02903 | 3.04703 | 2 | 5 | 96 | response to antineoplastic agent |
| GO:0050870 | 0.02930 | 2.29486 | 4 | 8 | 202 | positive regulation of T cell activation |
| GO:0090092 | 0.02991 | 2.16095 | 4 | 9 | 241 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0097696 | 0.03003 | 2.44723 | 3 | 7 | 166 | STAT cascade |
| GO:0030278 | 0.03005 | 2.28296 | 4 | 8 | 203 | regulation of ossification |
| GO:0006732 | 0.03010 | 1.86355 | 7 | 13 | 403 | coenzyme metabolic process |
| GO:0043255 | 0.03017 | 3.01374 | 2 | 5 | 97 | regulation of carbohydrate biosynthetic process |
| GO:0015804 | 0.03018 | 4.73915 | 1 | 3 | 38 | neutral amino acid transport |
| GO:0019068 | 0.03018 | 4.73915 | 1 | 3 | 38 | virion assembly |
| GO:1900077 | 0.03018 | 4.73915 | 1 | 3 | 38 | negative regulation of cellular response to insulin stimulus |
| GO:1902742 | 0.03018 | 4.73915 | 1 | 3 | 38 | apoptotic process involved in development |
| GO:1905898 | 0.03018 | 4.73915 | 1 | 3 | 38 | positive regulation of response to endoplasmic reticulum stress |
| GO:0045428 | 0.03047 | 3.57263 | 1 | 4 | 66 | regulation of nitric oxide biosynthetic process |
| GO:0072171 | 0.03047 | 3.57263 | 1 | 4 | 66 | mesonephric tubule morphogenesis |
| GO:1902807 | 0.03051 | 2.66502 | 2 | 6 | 131 | negative regulation of cell cycle G1/S phase transition |
| GO:0009914 | 0.03092 | 1.97381 | 6 | 11 | 322 | hormone transport |
| GO:0060562 | 0.03092 | 1.97381 | 6 | 11 | 322 | epithelial tube morphogenesis |
| GO:0018108 | 0.03095 | 1.90954 | 6 | 12 | 363 | peptidyl-tyrosine phosphorylation |
| GO:0034614 | 0.03175 | 2.41657 | 3 | 7 | 168 | cellular response to reactive oxygen species |
| GO:0071706 | 0.03175 | 2.41657 | 3 | 7 | 168 | tumor necrosis factor superfamily cytokine production |
| GO:0019439 | 0.03181 | 1.62402 | 13 | 20 | 712 | aromatic compound catabolic process |
| GO:0048662 | 0.03197 | 3.51573 | 1 | 4 | 67 | negative regulation of smooth muscle cell proliferation |
| GO:0010761 | 0.03227 | 4.60725 | 1 | 3 | 39 | fibroblast migration |
| GO:0002070 | 0.03246 | 7.88382 | 0 | 2 | 16 | epithelial cell maturation |
| GO:0002830 | 0.03246 | 7.88382 | 0 | 2 | 16 | positive regulation of type 2 immune response |
| GO:0007567 | 0.03246 | 7.88382 | 0 | 2 | 16 | parturition |
| GO:0010566 | 0.03246 | 7.88382 | 0 | 2 | 16 | regulation of ketone biosynthetic process |
| GO:0030952 | 0.03246 | 7.88382 | 0 | 2 | 16 | establishment or maintenance of cytoskeleton polarity |
| GO:0031958 | 0.03246 | 7.88382 | 0 | 2 | 16 | corticosteroid receptor signaling pathway |
| GO:0042448 | 0.03246 | 7.88382 | 0 | 2 | 16 | progesterone metabolic process |
| GO:0043031 | 0.03246 | 7.88382 | 0 | 2 | 16 | negative regulation of macrophage activation |
| GO:0043252 | 0.03246 | 7.88382 | 0 | 2 | 16 | sodium-independent organic anion transport |
| GO:0044849 | 0.03246 | 7.88382 | 0 | 2 | 16 | estrous cycle |
| GO:0051447 | 0.03246 | 7.88382 | 0 | 2 | 16 | negative regulation of meiotic cell cycle |
| GO:0090036 | 0.03246 | 7.88382 | 0 | 2 | 16 | regulation of protein kinase C signaling |
| GO:0090335 | 0.03246 | 7.88382 | 0 | 2 | 16 | regulation of brown fat cell differentiation |
| GO:0097067 | 0.03246 | 7.88382 | 0 | 2 | 16 | cellular response to thyroid hormone stimulus |
| GO:1902001 | 0.03246 | 7.88382 | 0 | 2 | 16 | fatty acid transmembrane transport |
| GO:0042770 | 0.03252 | 2.62277 | 2 | 6 | 133 | signal transduction in response to DNA damage |
| GO:0070301 | 0.03255 | 2.94930 | 2 | 5 | 99 | cellular response to hydrogen peroxide |
| GO:0018212 | 0.03266 | 1.89304 | 7 | 12 | 366 | peptidyl-tyrosine modification |
| GO:0015980 | 0.03303 | 2.02705 | 5 | 10 | 285 | energy derivation by oxidation of organic compounds |
| GO:0006733 | 0.03317 | 2.23658 | 4 | 8 | 207 | oxidoreduction coenzyme metabolic process |
| GO:0002292 | 0.03350 | 3.46061 | 1 | 4 | 68 | T cell differentiation involved in immune response |
| GO:0050918 | 0.03350 | 3.46061 | 1 | 4 | 68 | positive chemotaxis |
| GO:0006165 | 0.03355 | 2.60213 | 2 | 6 | 134 | nucleoside diphosphate phosphorylation |
| GO:0043009 | 0.03373 | 1.65807 | 11 | 18 | 627 | chordate embryonic development |
| GO:0010657 | 0.03378 | 2.91809 | 2 | 5 | 100 | muscle cell apoptotic process |
| GO:0034446 | 0.03378 | 2.91809 | 2 | 5 | 100 | substrate adhesion-dependent cell spreading |
| GO:0009124 | 0.03398 | 2.22528 | 4 | 8 | 208 | nucleoside monophosphate biosynthetic process |
| GO:0010506 | 0.03401 | 1.94204 | 6 | 11 | 327 | regulation of autophagy |
| GO:0006734 | 0.03444 | 4.48249 | 1 | 3 | 40 | NADH metabolic process |
| GO:0009268 | 0.03444 | 4.48249 | 1 | 3 | 40 | response to pH |
| GO:0071470 | 0.03444 | 4.48249 | 1 | 3 | 40 | cellular response to osmotic stress |
| GO:0071548 | 0.03444 | 4.48249 | 1 | 3 | 40 | response to dexamethasone |
| GO:0098760 | 0.03444 | 4.48249 | 1 | 3 | 40 | response to interleukin-7 |
| GO:0098761 | 0.03444 | 4.48249 | 1 | 3 | 40 | cellular response to interleukin-7 |
| GO:0009206 | 0.03446 | 2.37197 | 3 | 7 | 171 | purine ribonucleoside triphosphate biosynthetic process |
| GO:0016570 | 0.03467 | 1.77943 | 8 | 14 | 454 | histone modification |
| GO:0044281 | 0.03504 | 1.35397 | 38 | 49 | 2115 | small molecule metabolic process |
| GO:0032611 | 0.03504 | 2.88754 | 2 | 5 | 101 | interleukin-1 beta production |
| GO:1903426 | 0.03504 | 2.88754 | 2 | 5 | 101 | regulation of reactive oxygen species biosynthetic process |
| GO:0071300 | 0.03508 | 3.40718 | 1 | 4 | 69 | cellular response to retinoic acid |
| GO:0048562 | 0.03509 | 2.00484 | 5 | 10 | 288 | embryonic organ morphogenesis |
| GO:0009145 | 0.03540 | 2.35746 | 3 | 7 | 172 | purine nucleoside triphosphate biosynthetic process |
| GO:0032874 | 0.03540 | 2.35746 | 3 | 7 | 172 | positive regulation of stress-activated MAPK cascade |
| GO:0000294 | 0.03546 | 55.06006 | 0 | 1 | 2 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay |
| GO:0002017 | 0.03546 | 55.06006 | 0 | 1 | 2 | regulation of blood volume by renal aldosterone |
| GO:0002304 | 0.03546 | 55.06006 | 0 | 1 | 2 | gamma-delta intraepithelial T cell differentiation |
| GO:0002305 | 0.03546 | 55.06006 | 0 | 1 | 2 | CD8-positive, gamma-delta intraepithelial T cell differentiation |
| GO:0002384 | 0.03546 | 55.06006 | 0 | 1 | 2 | hepatic immune response |
| GO:0002508 | 0.03546 | 55.06006 | 0 | 1 | 2 | central tolerance induction |
| GO:0002635 | 0.03546 | 55.06006 | 0 | 1 | 2 | negative regulation of germinal center formation |
| GO:0002661 | 0.03546 | 55.06006 | 0 | 1 | 2 | regulation of B cell tolerance induction |
| GO:0002663 | 0.03546 | 55.06006 | 0 | 1 | 2 | positive regulation of B cell tolerance induction |
| GO:0003169 | 0.03546 | 55.06006 | 0 | 1 | 2 | coronary vein morphogenesis |
| GO:0003218 | 0.03546 | 55.06006 | 0 | 1 | 2 | cardiac left ventricle formation |
| GO:0006867 | 0.03546 | 55.06006 | 0 | 1 | 2 | asparagine transport |
| GO:0007542 | 0.03546 | 55.06006 | 0 | 1 | 2 | primary sex determination, germ-line |
| GO:0009258 | 0.03546 | 55.06006 | 0 | 1 | 2 | 10-formyltetrahydrofolate catabolic process |
| GO:0014036 | 0.03546 | 55.06006 | 0 | 1 | 2 | neural crest cell fate specification |
| GO:0014740 | 0.03546 | 55.06006 | 0 | 1 | 2 | negative regulation of muscle hyperplasia |
| GO:0015817 | 0.03546 | 55.06006 | 0 | 1 | 2 | histidine transport |
| GO:0015881 | 0.03546 | 55.06006 | 0 | 1 | 2 | creatine transmembrane transport |
| GO:0018352 | 0.03546 | 55.06006 | 0 | 1 | 2 | protein-pyridoxal-5-phosphate linkage |
| GO:0018992 | 0.03546 | 55.06006 | 0 | 1 | 2 | germ-line sex determination |
| GO:0019100 | 0.03546 | 55.06006 | 0 | 1 | 2 | male germ-line sex determination |
| GO:0019516 | 0.03546 | 55.06006 | 0 | 1 | 2 | lactate oxidation |
| GO:0019543 | 0.03546 | 55.06006 | 0 | 1 | 2 | propionate catabolic process |
| GO:0031635 | 0.03546 | 55.06006 | 0 | 1 | 2 | adenylate cyclase-inhibiting opioid receptor signaling pathway |
| GO:0032499 | 0.03546 | 55.06006 | 0 | 1 | 2 | detection of peptidoglycan |
| GO:0034352 | 0.03546 | 55.06006 | 0 | 1 | 2 | positive regulation of glial cell apoptotic process |
| GO:0034439 | 0.03546 | 55.06006 | 0 | 1 | 2 | lipoprotein lipid oxidation |
| GO:0034442 | 0.03546 | 55.06006 | 0 | 1 | 2 | regulation of lipoprotein oxidation |
| GO:0034633 | 0.03546 | 55.06006 | 0 | 1 | 2 | retinol transport |
| GO:0034758 | 0.03546 | 55.06006 | 0 | 1 | 2 | positive regulation of iron ion transport |
| GO:0034761 | 0.03546 | 55.06006 | 0 | 1 | 2 | positive regulation of iron ion transmembrane transport |
| GO:0035026 | 0.03546 | 55.06006 | 0 | 1 | 2 | leading edge cell differentiation |
| GO:0035801 | 0.03546 | 55.06006 | 0 | 1 | 2 | adrenal cortex development |
| GO:0035802 | 0.03546 | 55.06006 | 0 | 1 | 2 | adrenal cortex formation |
| GO:0036496 | 0.03546 | 55.06006 | 0 | 1 | 2 | regulation of translational initiation by eIF2 alpha dephosphorylation |
| GO:0038161 | 0.03546 | 55.06006 | 0 | 1 | 2 | prolactin signaling pathway |
| GO:0038190 | 0.03546 | 55.06006 | 0 | 1 | 2 | VEGF-activated neuropilin signaling pathway |
| GO:0042160 | 0.03546 | 55.06006 | 0 | 1 | 2 | lipoprotein modification |
| GO:0042161 | 0.03546 | 55.06006 | 0 | 1 | 2 | lipoprotein oxidation |
| GO:0042231 | 0.03546 | 55.06006 | 0 | 1 | 2 | interleukin-13 biosynthetic process |
| GO:0042361 | 0.03546 | 55.06006 | 0 | 1 | 2 | menaquinone catabolic process |
| GO:0042377 | 0.03546 | 55.06006 | 0 | 1 | 2 | vitamin K catabolic process |
| GO:0043377 | 0.03546 | 55.06006 | 0 | 1 | 2 | negative regulation of CD8-positive, alpha-beta T cell differentiation |
| GO:0043974 | 0.03546 | 55.06006 | 0 | 1 | 2 | histone H3-K27 acetylation |
| GO:0044324 | 0.03546 | 55.06006 | 0 | 1 | 2 | regulation of transcription involved in anterior/posterior axis specification |
| GO:0045168 | 0.03546 | 55.06006 | 0 | 1 | 2 | cell-cell signaling involved in cell fate commitment |
| GO:0045404 | 0.03546 | 55.06006 | 0 | 1 | 2 | positive regulation of interleukin-4 biosynthetic process |
| GO:0045643 | 0.03546 | 55.06006 | 0 | 1 | 2 | regulation of eosinophil differentiation |
| GO:0045645 | 0.03546 | 55.06006 | 0 | 1 | 2 | positive regulation of eosinophil differentiation |
| GO:0045659 | 0.03546 | 55.06006 | 0 | 1 | 2 | negative regulation of neutrophil differentiation |
| GO:0046327 | 0.03546 | 55.06006 | 0 | 1 | 2 | glycerol biosynthetic process from pyruvate |
| GO:0046331 | 0.03546 | 55.06006 | 0 | 1 | 2 | lateral inhibition |
| GO:0046864 | 0.03546 | 55.06006 | 0 | 1 | 2 | isoprenoid transport |
| GO:0046865 | 0.03546 | 55.06006 | 0 | 1 | 2 | terpenoid transport |
| GO:0048342 | 0.03546 | 55.06006 | 0 | 1 | 2 | paraxial mesodermal cell differentiation |
| GO:0048343 | 0.03546 | 55.06006 | 0 | 1 | 2 | paraxial mesodermal cell fate commitment |
| GO:0051695 | 0.03546 | 55.06006 | 0 | 1 | 2 | actin filament uncapping |
| GO:0051941 | 0.03546 | 55.06006 | 0 | 1 | 2 | regulation of amino acid uptake involved in synaptic transmission |
| GO:0051946 | 0.03546 | 55.06006 | 0 | 1 | 2 | regulation of glutamate uptake involved in transmission of nerve impulse |
| GO:0060400 | 0.03546 | 55.06006 | 0 | 1 | 2 | negative regulation of growth hormone receptor signaling pathway |
| GO:0060468 | 0.03546 | 55.06006 | 0 | 1 | 2 | prevention of polyspermy |
| GO:0060516 | 0.03546 | 55.06006 | 0 | 1 | 2 | primary prostatic bud elongation |
| GO:0060532 | 0.03546 | 55.06006 | 0 | 1 | 2 | bronchus cartilage development |
| GO:0060587 | 0.03546 | 55.06006 | 0 | 1 | 2 | regulation of lipoprotein lipid oxidation |
| GO:0061102 | 0.03546 | 55.06006 | 0 | 1 | 2 | stomach neuroendocrine cell differentiation |
| GO:0061145 | 0.03546 | 55.06006 | 0 | 1 | 2 | lung smooth muscle development |
| GO:0061394 | 0.03546 | 55.06006 | 0 | 1 | 2 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance |
| GO:0070171 | 0.03546 | 55.06006 | 0 | 1 | 2 | negative regulation of tooth mineralization |
| GO:0071228 | 0.03546 | 55.06006 | 0 | 1 | 2 | cellular response to tumor cell |
| GO:0071505 | 0.03546 | 55.06006 | 0 | 1 | 2 | response to mycophenolic acid |
| GO:0071506 | 0.03546 | 55.06006 | 0 | 1 | 2 | cellular response to mycophenolic acid |
| GO:0072071 | 0.03546 | 55.06006 | 0 | 1 | 2 | kidney interstitial fibroblast differentiation |
| GO:0072141 | 0.03546 | 55.06006 | 0 | 1 | 2 | renal interstitial fibroblast development |
| GO:0072301 | 0.03546 | 55.06006 | 0 | 1 | 2 | regulation of metanephric glomerular mesangial cell proliferation |
| GO:0072554 | 0.03546 | 55.06006 | 0 | 1 | 2 | blood vessel lumenization |
| GO:0086097 | 0.03546 | 55.06006 | 0 | 1 | 2 | phospholipase C-activating angiotensin-activated signaling pathway |
| GO:0090362 | 0.03546 | 55.06006 | 0 | 1 | 2 | positive regulation of platelet-derived growth factor production |
| GO:0090663 | 0.03546 | 55.06006 | 0 | 1 | 2 | galanin-activated signaling pathway |
| GO:0097324 | 0.03546 | 55.06006 | 0 | 1 | 2 | melanocyte migration |
| GO:0120063 | 0.03546 | 55.06006 | 0 | 1 | 2 | stomach smooth muscle contraction |
| GO:1900141 | 0.03546 | 55.06006 | 0 | 1 | 2 | regulation of oligodendrocyte apoptotic process |
| GO:1901246 | 0.03546 | 55.06006 | 0 | 1 | 2 | regulation of lung ciliated cell differentiation |
| GO:1901551 | 0.03546 | 55.06006 | 0 | 1 | 2 | negative regulation of endothelial cell development |
| GO:1901674 | 0.03546 | 55.06006 | 0 | 1 | 2 | regulation of histone H3-K27 acetylation |
| GO:1902257 | 0.03546 | 55.06006 | 0 | 1 | 2 | negative regulation of apoptotic process involved in outflow tract morphogenesis |
| GO:1902310 | 0.03546 | 55.06006 | 0 | 1 | 2 | positive regulation of peptidyl-serine dephosphorylation |
| GO:1902336 | 0.03546 | 55.06006 | 0 | 1 | 2 | positive regulation of retinal ganglion cell axon guidance |
| GO:1902359 | 0.03546 | 55.06006 | 0 | 1 | 2 | Notch signaling pathway involved in somitogenesis |
| GO:1902366 | 0.03546 | 55.06006 | 0 | 1 | 2 | regulation of Notch signaling pathway involved in somitogenesis |
| GO:1902367 | 0.03546 | 55.06006 | 0 | 1 | 2 | negative regulation of Notch signaling pathway involved in somitogenesis |
| GO:1902690 | 0.03546 | 55.06006 | 0 | 1 | 2 | positive regulation of NAD metabolic process |
| GO:1903141 | 0.03546 | 55.06006 | 0 | 1 | 2 | negative regulation of establishment of endothelial barrier |
| GO:1903937 | 0.03546 | 55.06006 | 0 | 1 | 2 | response to acrylamide |
| GO:1904025 | 0.03546 | 55.06006 | 0 | 1 | 2 | positive regulation of glucose catabolic process to lactate via pyruvate |
| GO:1904071 | 0.03546 | 55.06006 | 0 | 1 | 2 | presynaptic active zone assembly |
| GO:1904245 | 0.03546 | 55.06006 | 0 | 1 | 2 | regulation of polynucleotide adenylyltransferase activity |
| GO:1904440 | 0.03546 | 55.06006 | 0 | 1 | 2 | positive regulation of ferrous iron import across plasma membrane |
| GO:1904556 | 0.03546 | 55.06006 | 0 | 1 | 2 | L-tryptophan transmembrane transport |
| GO:1904613 | 0.03546 | 55.06006 | 0 | 1 | 2 | cellular response to 2,3,7,8-tetrachlorodibenzodioxine |
| GO:1904831 | 0.03546 | 55.06006 | 0 | 1 | 2 | positive regulation of aortic smooth muscle cell differentiation |
| GO:1905179 | 0.03546 | 55.06006 | 0 | 1 | 2 | negative regulation of cardiac muscle tissue regeneration |
| GO:1905775 | 0.03546 | 55.06006 | 0 | 1 | 2 | negative regulation of DNA helicase activity |
| GO:1990708 | 0.03546 | 55.06006 | 0 | 1 | 2 | conditioned place preference |
| GO:2000016 | 0.03546 | 55.06006 | 0 | 1 | 2 | negative regulation of determination of dorsal identity |
| GO:2000098 | 0.03546 | 55.06006 | 0 | 1 | 2 | negative regulation of smooth muscle cell-matrix adhesion |
| GO:2000184 | 0.03546 | 55.06006 | 0 | 1 | 2 | positive regulation of progesterone biosynthetic process |
| GO:2000485 | 0.03546 | 55.06006 | 0 | 1 | 2 | regulation of glutamine transport |
| GO:2000627 | 0.03546 | 55.06006 | 0 | 1 | 2 | positive regulation of miRNA catabolic process |
| GO:0043523 | 0.03565 | 2.20300 | 4 | 8 | 210 | regulation of neuron apoptotic process |
| GO:0046939 | 0.03568 | 2.56182 | 2 | 6 | 136 | nucleotide phosphorylation |
| GO:0045926 | 0.03573 | 2.08800 | 4 | 9 | 249 | negative regulation of growth |
| GO:0002367 | 0.03633 | 2.85761 | 2 | 5 | 102 | cytokine production involved in immune response |
| GO:0070304 | 0.03635 | 2.34313 | 3 | 7 | 173 | positive regulation of stress-activated protein kinase signaling cascade |
| GO:0006978 | 0.03636 | 7.35783 | 0 | 2 | 17 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
| GO:0042753 | 0.03636 | 7.35783 | 0 | 2 | 17 | positive regulation of circadian rhythm |
| GO:0043923 | 0.03636 | 7.35783 | 0 | 2 | 17 | positive regulation by host of viral transcription |
| GO:0061318 | 0.03636 | 7.35783 | 0 | 2 | 17 | renal filtration cell differentiation |
| GO:0071850 | 0.03636 | 7.35783 | 0 | 2 | 17 | mitotic cell cycle arrest |
| GO:0072112 | 0.03636 | 7.35783 | 0 | 2 | 17 | glomerular visceral epithelial cell differentiation |
| GO:0019432 | 0.03668 | 4.36429 | 1 | 3 | 41 | triglyceride biosynthetic process |
| GO:0034122 | 0.03668 | 4.36429 | 1 | 3 | 41 | negative regulation of toll-like receptor signaling pathway |
| GO:0048286 | 0.03668 | 4.36429 | 1 | 3 | 41 | lung alveolus development |
| GO:0050873 | 0.03668 | 4.36429 | 1 | 3 | 41 | brown fat cell differentiation |
| GO:0061028 | 0.03668 | 4.36429 | 1 | 3 | 41 | establishment of endothelial barrier |
| GO:0150077 | 0.03668 | 4.36429 | 1 | 3 | 41 | regulation of neuroinflammatory response |
| GO:0034121 | 0.03670 | 3.35537 | 1 | 4 | 70 | regulation of toll-like receptor signaling pathway |
| GO:0001701 | 0.03691 | 1.85561 | 7 | 12 | 373 | in utero embryonic development |
| GO:0045637 | 0.03729 | 2.07051 | 4 | 9 | 251 | regulation of myeloid cell differentiation |
| GO:0051345 | 0.03749 | 1.57319 | 14 | 21 | 771 | positive regulation of hydrolase activity |
| GO:0032652 | 0.03765 | 2.82830 | 2 | 5 | 103 | regulation of interleukin-1 production |
| GO:0035601 | 0.03765 | 2.82830 | 2 | 5 | 103 | protein deacylation |
| GO:0008584 | 0.03790 | 2.52273 | 2 | 6 | 138 | male gonad development |
| GO:0030048 | 0.03790 | 2.52273 | 2 | 6 | 138 | actin filament-based movement |
| GO:0002695 | 0.03830 | 2.31498 | 3 | 7 | 175 | negative regulation of leukocyte activation |
| GO:0071479 | 0.03837 | 3.30511 | 1 | 4 | 71 | cellular response to ionizing radiation |
| GO:0071902 | 0.03869 | 1.89921 | 6 | 11 | 334 | positive regulation of protein serine/threonine kinase activity |
| GO:0098732 | 0.03899 | 2.79958 | 2 | 5 | 104 | macromolecule deacylation |
| GO:1903146 | 0.03900 | 4.25215 | 1 | 3 | 42 | regulation of autophagy of mitochondrion |
| GO:0016571 | 0.03904 | 2.50362 | 2 | 6 | 139 | histone methylation |
| GO:0046546 | 0.03904 | 2.50362 | 2 | 6 | 139 | development of primary male sexual characteristics |
| GO:0007254 | 0.03915 | 2.15975 | 4 | 8 | 214 | JNK cascade |
| GO:0050796 | 0.03931 | 2.30116 | 3 | 7 | 176 | regulation of insulin secretion |
| GO:0060322 | 0.03972 | 1.56233 | 14 | 21 | 776 | head development |
| GO:0002532 | 0.04007 | 3.25633 | 1 | 4 | 72 | production of molecular mediator involved in inflammatory response |
| GO:0006635 | 0.04007 | 3.25633 | 1 | 4 | 72 | fatty acid beta-oxidation |
| GO:0042737 | 0.04020 | 2.48480 | 3 | 6 | 140 | drug catabolic process |
| GO:0009201 | 0.04033 | 2.28750 | 3 | 7 | 177 | ribonucleoside triphosphate biosynthetic process |
| GO:0032006 | 0.04037 | 2.77143 | 2 | 5 | 105 | regulation of TOR signaling |
| GO:0001819 | 0.04041 | 1.73892 | 8 | 14 | 464 | positive regulation of cytokine production |
| GO:0045786 | 0.04043 | 1.61953 | 11 | 18 | 641 | negative regulation of cell cycle |
| GO:0006704 | 0.04043 | 6.89759 | 0 | 2 | 18 | glucocorticoid biosynthetic process |
| GO:0009312 | 0.04043 | 6.89759 | 0 | 2 | 18 | oligosaccharide biosynthetic process |
| GO:0031998 | 0.04043 | 6.89759 | 0 | 2 | 18 | regulation of fatty acid beta-oxidation |
| GO:0035994 | 0.04043 | 6.89759 | 0 | 2 | 18 | response to muscle stretch |
| GO:0042772 | 0.04043 | 6.89759 | 0 | 2 | 18 | DNA damage response, signal transduction resulting in transcription |
| GO:0051957 | 0.04043 | 6.89759 | 0 | 2 | 18 | positive regulation of amino acid transport |
| GO:0060192 | 0.04043 | 6.89759 | 0 | 2 | 18 | negative regulation of lipase activity |
| GO:0060977 | 0.04043 | 6.89759 | 0 | 2 | 18 | coronary vasculature morphogenesis |
| GO:0072077 | 0.04043 | 6.89759 | 0 | 2 | 18 | renal vesicle morphogenesis |
| GO:0090190 | 0.04043 | 6.89759 | 0 | 2 | 18 | positive regulation of branching involved in ureteric bud morphogenesis |
| GO:0150079 | 0.04043 | 6.89759 | 0 | 2 | 18 | negative regulation of neuroinflammatory response |
| GO:2000647 | 0.04043 | 6.89759 | 0 | 2 | 18 | negative regulation of stem cell proliferation |
| GO:0032869 | 0.04099 | 2.13874 | 4 | 8 | 216 | cellular response to insulin stimulus |
| GO:0001818 | 0.04103 | 1.94790 | 5 | 10 | 296 | negative regulation of cytokine production |
| GO:0034198 | 0.04138 | 4.14562 | 1 | 3 | 43 | cellular response to amino acid starvation |
| GO:0045429 | 0.04138 | 4.14562 | 1 | 3 | 43 | positive regulation of nitric oxide biosynthetic process |
| GO:0045687 | 0.04138 | 4.14562 | 1 | 3 | 43 | positive regulation of glial cell differentiation |
| GO:0045746 | 0.04138 | 4.14562 | 1 | 3 | 43 | negative regulation of Notch signaling pathway |
| GO:0046460 | 0.04138 | 4.14562 | 1 | 3 | 43 | neutral lipid biosynthetic process |
| GO:0046463 | 0.04138 | 4.14562 | 1 | 3 | 43 | acylglycerol biosynthetic process |
| GO:0007187 | 0.04141 | 2.02804 | 5 | 9 | 256 | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0090596 | 0.04141 | 2.02804 | 5 | 9 | 256 | sensory organ morphogenesis |
| GO:0051056 | 0.04156 | 1.87556 | 6 | 11 | 338 | regulation of small GTPase mediated signal transduction |
| GO:0031100 | 0.04182 | 3.20896 | 1 | 4 | 73 | animal organ regeneration |
| GO:0043627 | 0.04182 | 3.20896 | 1 | 4 | 73 | response to estrogen |
| GO:0045685 | 0.04182 | 3.20896 | 1 | 4 | 73 | regulation of glial cell differentiation |
| GO:0060350 | 0.04182 | 3.20896 | 1 | 4 | 73 | endochondral bone morphogenesis |
| GO:0072401 | 0.04182 | 3.20896 | 1 | 4 | 73 | signal transduction involved in DNA integrity checkpoint |
| GO:0072422 | 0.04182 | 3.20896 | 1 | 4 | 73 | signal transduction involved in DNA damage checkpoint |
| GO:0008406 | 0.04192 | 2.12839 | 4 | 8 | 217 | gonad development |
| GO:0060348 | 0.04192 | 2.12839 | 4 | 8 | 217 | bone development |
| GO:0009792 | 0.04198 | 1.61150 | 12 | 18 | 644 | embryo development ending in birth or egg hatching |
| GO:0006479 | 0.04242 | 2.26065 | 3 | 7 | 179 | protein methylation |
| GO:0008213 | 0.04242 | 2.26065 | 3 | 7 | 179 | protein alkylation |
| GO:0051099 | 0.04242 | 2.26065 | 3 | 7 | 179 | positive regulation of binding |
| GO:0034332 | 0.04259 | 2.44799 | 3 | 6 | 142 | adherens junction organization |
| GO:1900542 | 0.04259 | 2.44799 | 3 | 6 | 142 | regulation of purine nucleotide metabolic process |
| GO:0062014 | 0.04320 | 2.71679 | 2 | 5 | 107 | negative regulation of small molecule metabolic process |
| GO:0071466 | 0.04349 | 2.24746 | 3 | 7 | 180 | cellular response to xenobiotic stimulus |
| GO:0072078 | 0.04361 | 3.16294 | 1 | 4 | 74 | nephron tubule morphogenesis |
| GO:0072395 | 0.04361 | 3.16294 | 1 | 4 | 74 | signal transduction involved in cell cycle checkpoint |
| GO:1900182 | 0.04361 | 3.16294 | 1 | 4 | 74 | positive regulation of protein localization to nucleus |
| GO:1903671 | 0.04361 | 3.16294 | 1 | 4 | 74 | negative regulation of sprouting angiogenesis |
| GO:0051186 | 0.04361 | 1.62726 | 11 | 17 | 602 | cofactor metabolic process |
| GO:0006631 | 0.04365 | 1.80459 | 7 | 12 | 383 | fatty acid metabolic process |
| GO:0006606 | 0.04382 | 2.42999 | 3 | 6 | 143 | protein import into nucleus |
| GO:0030879 | 0.04382 | 2.42999 | 3 | 6 | 143 | mammary gland development |
| GO:0035296 | 0.04382 | 2.42999 | 3 | 6 | 143 | regulation of tube diameter |
| GO:0044344 | 0.04382 | 2.42999 | 3 | 6 | 143 | cellular response to fibroblast growth factor stimulus |
| GO:0050880 | 0.04382 | 2.42999 | 3 | 6 | 143 | regulation of blood vessel size |
| GO:0097746 | 0.04382 | 2.42999 | 3 | 6 | 143 | regulation of blood vessel diameter |
| GO:0003197 | 0.04384 | 4.04429 | 1 | 3 | 44 | endocardial cushion development |
| GO:0003416 | 0.04384 | 4.04429 | 1 | 3 | 44 | endochondral bone growth |
| GO:0010463 | 0.04384 | 4.04429 | 1 | 3 | 44 | mesenchymal cell proliferation |
| GO:0010828 | 0.04384 | 4.04429 | 1 | 3 | 44 | positive regulation of glucose transmembrane transport |
| GO:0018023 | 0.04384 | 4.04429 | 1 | 3 | 44 | peptidyl-lysine trimethylation |
| GO:0030225 | 0.04384 | 4.04429 | 1 | 3 | 44 | macrophage differentiation |
| GO:0045601 | 0.04384 | 4.04429 | 1 | 3 | 44 | regulation of endothelial cell differentiation |
| GO:1903573 | 0.04384 | 4.04429 | 1 | 3 | 44 | negative regulation of response to endoplasmic reticulum stress |
| GO:1904407 | 0.04384 | 4.04429 | 1 | 3 | 44 | positive regulation of nitric oxide metabolic process |
| GO:0007267 | 0.04439 | 1.37250 | 30 | 39 | 1650 | cell-cell signaling |
| GO:0001710 | 0.04466 | 6.49150 | 0 | 2 | 19 | mesodermal cell fate commitment |
| GO:0003159 | 0.04466 | 6.49150 | 0 | 2 | 19 | morphogenesis of an endothelium |
| GO:0003422 | 0.04466 | 6.49150 | 0 | 2 | 19 | growth plate cartilage morphogenesis |
| GO:0036303 | 0.04466 | 6.49150 | 0 | 2 | 19 | lymph vessel morphogenesis |
| GO:0045076 | 0.04466 | 6.49150 | 0 | 2 | 19 | regulation of interleukin-2 biosynthetic process |
| GO:0045947 | 0.04466 | 6.49150 | 0 | 2 | 19 | negative regulation of translational initiation |
| GO:0060004 | 0.04466 | 6.49150 | 0 | 2 | 19 | reflex |
| GO:0060438 | 0.04466 | 6.49150 | 0 | 2 | 19 | trachea development |
| GO:0061154 | 0.04466 | 6.49150 | 0 | 2 | 19 | endothelial tube morphogenesis |
| GO:0071435 | 0.04466 | 6.49150 | 0 | 2 | 19 | potassium ion export |
| GO:0072087 | 0.04466 | 6.49150 | 0 | 2 | 19 | renal vesicle development |
| GO:0097623 | 0.04466 | 6.49150 | 0 | 2 | 19 | potassium ion export across plasma membrane |
| GO:1905288 | 0.04466 | 6.49150 | 0 | 2 | 19 | vascular associated smooth muscle cell apoptotic process |
| GO:1905459 | 0.04466 | 6.49150 | 0 | 2 | 19 | regulation of vascular associated smooth muscle cell apoptotic process |
| GO:1905939 | 0.04466 | 6.49150 | 0 | 2 | 19 | regulation of gonad development |
| GO:0009062 | 0.04467 | 2.69026 | 2 | 5 | 108 | fatty acid catabolic process |
| GO:0071156 | 0.04467 | 2.69026 | 2 | 5 | 108 | regulation of cell cycle arrest |
| GO:0035150 | 0.04506 | 2.41225 | 3 | 6 | 144 | regulation of tube size |
| GO:1904064 | 0.04506 | 2.41225 | 3 | 6 | 144 | positive regulation of cation transmembrane transport |
| GO:0150076 | 0.04545 | 3.11822 | 1 | 4 | 75 | neuroinflammatory response |
| GO:0050708 | 0.04547 | 1.70778 | 8 | 14 | 472 | regulation of protein secretion |
| GO:0044255 | 0.04591 | 1.45670 | 19 | 27 | 1071 | cellular lipid metabolic process |
| GO:0001974 | 0.04637 | 3.94778 | 1 | 3 | 45 | blood vessel remodeling |
| GO:0034504 | 0.04675 | 1.97929 | 5 | 9 | 262 | protein localization to nucleus |
| GO:0016569 | 0.04680 | 1.70016 | 8 | 14 | 474 | covalent chromatin modification |
| GO:1901361 | 0.04713 | 1.54720 | 13 | 20 | 745 | organic cyclic compound catabolic process |
| GO:0019674 | 0.04732 | 3.07475 | 1 | 4 | 76 | NAD metabolic process |
| GO:0030500 | 0.04732 | 3.07475 | 1 | 4 | 76 | regulation of bone mineralization |
| GO:0002224 | 0.04763 | 2.37753 | 3 | 6 | 146 | toll-like receptor signaling pathway |
| GO:0006140 | 0.04763 | 2.37753 | 3 | 6 | 146 | regulation of nucleotide metabolic process |
| GO:0051250 | 0.04763 | 2.37753 | 3 | 6 | 146 | negative regulation of lymphocyte activation |
| GO:0065007 | 0.04770 | 1.23610 | 229 | 243 | 12777 | biological regulation |
| GO:2000045 | 0.04795 | 2.19619 | 3 | 7 | 184 | regulation of G1/S transition of mitotic cell cycle |
| GO:0097191 | 0.04889 | 2.05862 | 4 | 8 | 224 | extrinsic apoptotic signaling pathway |
| GO:0010883 | 0.04897 | 3.85576 | 1 | 3 | 46 | regulation of lipid storage |
| GO:0050706 | 0.04897 | 3.85576 | 1 | 3 | 46 | regulation of interleukin-1 beta secretion |
| GO:1990928 | 0.04897 | 3.85576 | 1 | 3 | 46 | response to amino acid starvation |
| GO:0002320 | 0.04905 | 6.13052 | 0 | 2 | 20 | lymphoid progenitor cell differentiation |
| GO:0002374 | 0.04905 | 6.13052 | 0 | 2 | 20 | cytokine secretion involved in immune response |
| GO:0003323 | 0.04905 | 6.13052 | 0 | 2 | 20 | type B pancreatic cell development |
| GO:0030903 | 0.04905 | 6.13052 | 0 | 2 | 20 | notochord development |
| GO:0031061 | 0.04905 | 6.13052 | 0 | 2 | 20 | negative regulation of histone methylation |
| GO:0032042 | 0.04905 | 6.13052 | 0 | 2 | 20 | mitochondrial DNA metabolic process |
| GO:0036065 | 0.04905 | 6.13052 | 0 | 2 | 20 | fucosylation |
| GO:0042276 | 0.04905 | 6.13052 | 0 | 2 | 20 | error-prone translesion synthesis |
| GO:0043586 | 0.04905 | 6.13052 | 0 | 2 | 20 | tongue development |
| GO:0051767 | 0.04905 | 6.13052 | 0 | 2 | 20 | nitric-oxide synthase biosynthetic process |
| GO:0051769 | 0.04905 | 6.13052 | 0 | 2 | 20 | regulation of nitric-oxide synthase biosynthetic process |
| GO:0060008 | 0.04905 | 6.13052 | 0 | 2 | 20 | Sertoli cell differentiation |
| GO:0060039 | 0.04905 | 6.13052 | 0 | 2 | 20 | pericardium development |
| GO:0060602 | 0.04905 | 6.13052 | 0 | 2 | 20 | branch elongation of an epithelium |
| GO:0070262 | 0.04905 | 6.13052 | 0 | 2 | 20 | peptidyl-serine dephosphorylation |
| GO:0070932 | 0.04905 | 6.13052 | 0 | 2 | 20 | histone H3 deacetylation |
| GO:0070987 | 0.04905 | 6.13052 | 0 | 2 | 20 | error-free translesion synthesis |
| GO:1903599 | 0.04905 | 6.13052 | 0 | 2 | 20 | positive regulation of autophagy of mitochondrion |
| GO:0006809 | 0.04924 | 3.03246 | 1 | 4 | 77 | nitric oxide biosynthetic process |